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General introduction
Since the introduction of penicillins in patient care in 1941 a
dramatic improvement in the treatment of infectious diseases
was achieved.1 Antibiotics have considerably changed the
epidemiology and prognosis of infectious diseases. Diseases
like malaria, tuberculosis and rheumatic fever were no longer
untreatable and the morbidity and mortality related to these
diseases were reduced tremendously. Complications of
frequent bacterial infections such as otitis media have become
rare and the mortality and morbidity of severe infections as
meningitis and osteomyelitis have been reduced. Antibiotics
were considered miracle drugs during the second half of the
previous century. The number of new agents developed in the
decades following the discovery of penicillin is striking. 
The development of newer generation antibiotics created a
number of advantages in treatment of bacterial diseases like a
better penetration, faster sterilisation of infected body sites,
easier use and last but not least less toxicity. The treatment of
bacterial meningitis over the past 35 years is exemplary for this
evolution. Common childhood meningitis was treated with
several antibiotics like sulphonamides or penicillins in the late
1940s, mostly in monotherapy or in combinations of
sulphonamides, penicillin G and streptomycin. The
introduction of chloramphenicol in the early 1950s resulted in
the abandonment of the toxic streptomycin and increased the
effectiveness of the treatment of meningitis by the most
common pathogens H. influenzae, N. meningitides and S.
pneumoniae. Treatment with a single drug was theoretically
possible, however, ÒtripleÓ therapy with penicillin,
chloramphenicol and a sulphonamide continued to be widely
employed except in developing countries where monotherapy
with chloramphenicol is still used today. 2 Finally due to the
availability of several suitable drugs of the cephalosporin
9
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group, the current standard is monotherapy with a third
generation cephalosporin. This treatment with a third
generation cephalosporin is safe, probably effective even
against ampicillin and chloramphenicol-resistant H. influenzae,
and intermediate penicillin-resistant pneumococci and
aminoglycoside resistant enterobacteria.3 Newer drugs have
not replaced older antibiotics but do provide the physician
with a broader range of choices for the treatment of many
infectious diseases, allowing more individualization of
therapy.3
Two important events however occurred concurrently with the
increased use of newer agents: expanding costs and
development of resistance. Antibiotics account for a substantial
proportion of the expenditure in pharmacies and hospitals. In
children antibiotics are among the most commonly prescribed
drugs.4 Several studies at the end of the 1970s focusing on
antibiotic prescribing attitudes in hospitalised children indicate
that approximately 35% of admitted infants and children
receive antibiotics.4-8 In outpatient settings even higher
percentages were found.9 Moreover since the development and
introduction of the first antibiotic, these powerful drugs have
been overused and misused. Almost half of all antibiotic
prescriptions were found to be inappropriate, based on clinical
and financial criteria.10,11
Because of the rising costs in health care, lack of uniformity in
prescribing attitudes and the emergence of antibiotic
resistance, monitoring and controlling antibiotic use is
needed.12,13 Several Dutch persons were interested in these data
and did some excellent research. Gysens described the use of
antimicrobial drugs in a university hospital, measured by
several cost-entered methods.14 In the Netherlands, a strong
national health policy against overuse of antibiotics and a
tradition of prudent antimicrobial drug use has been
institutionalised. Socio-economic factors and marketing
pressures which lead to inappropriate use are thus controlled
and physicians are educated likewise in this tradition. This has
General introduction
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been recently documented by Stobberingh who studied Dutch
guidelines for prescription.15 However, there is room for
improvement. Janknegt described the antibiotic policy in
Dutch hospitals by studying antibiotic formularies.16 He
demonstrated that the situation regarding the availability of
antibiotic formularies in the Netherlands is not ideal and that
an active policy in hospitals concerning the preparation of an
antibiotic formulary is recommended. 
Next to these data if we wanted to get more informed about
the resistance pattern in the Netherlands several surveillance
studies were performed. And collected data from eight
laboratories, representing about 30% of the Dutch samples sent
for culture, giving a detailed estimate of the antibiotic
resistance in Gram-negative bacteria and Gram-positive
bacteria in the Netherlands.17-19 In addition continuous
surveillance of antibiotic resistance in Staphylococcus aureus and
coagulase-negative staphylococci is performed in nine Dutch
public health laboratories.20 Finally the susceptibility of strains
of Methicillin Resistant Staphylocoocus Aureus (MRSA) from
local laboratories to the National Institute of Public Health and
Environmental Protection is continuously being analysed. In
general these studies show that antibiotic resistance in the
Netherlands is relatively low compared with other countries.
This was confirmed in a clinical study on severe infections in
hospitalised patients.21 The surveillance of resistance of
staphylococci by an electronic network over a 6 year period
showed a very low percentage of methicillin resistance in
S.aureus.22
From this data we know more in detail about the incidence of
antibiotic resistance but the most important motivation for an
optimal use of antimicrobial agents is the relationship between
antibiotic use and antibiotic resistance. Several studies show a
correlation between antibiotic resistance and antibiotic
consumption.23,24 Much of the attention on antimicrobial
resistance has been focused on nosocomial or hospital-
acquired infections.25 Hospitals have experienced periodic
General introduction
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episodes of antimicrobial resistance affecting a variety of
organisms, beginning with the emergence of penicillin-
resistant staphylococci in the early 1950s. Subsequent
nosocomial problems have included the emergence of various
resistant Gram-negative organisms, methicillin-resistant
staphylococci, and most recent vancomycin-resistant
enterococci and multidrug-resistant M.tuberculosis. There are
other organisms, such as multidrug-resistant Gram-negative
bacilli, that produce important nosocomial problems. Likewise
a number of community-acquired bacterial pathogens are
developing increased antimicrobial resistance. Antimicrobial
resistance in community-acquired organisms occurs when
organisms are transmitted from hospitals or animal farms but
also emerges within the community itself in response to
selective pressure of antimicrobial use.25 It is not only a
problem on the national level but resistant organisms can also
be transmitted between communities, making resistance a
worldwide problem. Antimicrobial resistance increases the
morbidity, mortality, and the costs associated with the disease
of diseases. Various factors are involved in the development of
resistance including microbial characteristics, environmental
animal or human reservoirs in which resistant genes or
resistant organisms can persist, patterns of antimicrobial use,
and socio-economic and technologic changes that affect the
transmission of organisms. Various combinations of these
factors determine the frequency of occurrence of drug-resistant
organisms.25 Several strategies are available to counteract this
public health emergency. A clear antibiotic policy is essential
for preventing the rapid and wide-spread development of
resistance, focused on empiric antibiotic therapy, prophylactic
and long-term use of antibiotics.25,26 To keep the resistance at a
low level it is of paramount importance to limit the use of
antibiotics. A positive correlation between the turnover of
broad spectrum penicillins in various hospital departments
and the incidence of resistant strains in patients in these
departments could be found.27 It has been shown that
General introduction
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increased bacterial resistance in a hospital department is
reversible by discontinuation or reduction of antimicrobial
therapy.28-30 Periodic monitoring of resistance should be
performed. At regular intervals surveillance studies should be
performed in several places, preferably in urban communities
and in areas with intensive live-stock farming. On the basis of
these studies an estimate should be made of the prevalence of
resistant strains. The results of these studies can be used to
formulate guidelines for the use of antimicrobial drugs in
human as well as in veterinary medicine. These guidelines can
be modified, if necessary. Several professional societies have
issued guidelines designed to reduce the use of antibiotics
world-wide by means of various control strategies.31-34 For
example the impact of a clinical infectious disease task force
with a clinician, medical microbiologist and a pharmacist will
be of great importance to streamline the appropriateness of
antimicrobial therapy.35 This will also be a way to get more
insight in the use of antibiotics and to try to define rules for a
more rational and appropriate usage of antibiotics. 
Although the above mentioned situation in the Netherlands is
acceptable, we think it important to improve this situation and
to get people aware of the consequences of antibiotic use. Until
now there has been no research in general medicine nor in
paediatrics to gain a better insight in the situation of antibiotic
related costs and prescription patterns. Nor was there any
research on the knowledge of doctors regarding antibiotics and
the situation of resistance. Therefore we started a study in a
paediatric university hospital concerning all these data as
described in this thesis. 
The study was started in August 1995 and focuses on
analysing antibiotic prescribing trends in relation to costs and
antibiotic resistance. The study consists of a number of phases,
starting with an inventory of important variables (antibiotic
expenditure, use of antibiotics in daily practice, uniformity in
prescribing behaviour). During the next phase a project group
was formed to reach a consensus or a solution for the
General introduction
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problems defined in the first phase. After this an
implementation phase was started in which all the defined
solutions were used in the daily practice of the hospital.
Finally a continuous surveillance was performed in which all
variables were analysed again and compared with the initial
results. After a period of three years the study was concluded
by formulating guidelines for the future. The above mentioned
phases of the study were defined as aims of the study. 
General introduction
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Aims of the study
Analysing costs relating to prescription of antibiotics in a
tertiary care paediatric department.
(chapter 2 and 5)
Analysing physiciansÕ prescribing attitudes regarding
antibiotics.
(chapter 3) 
Studying the impact of a more rational usage of antibiotics on
antibiotic-related costs.
(chapter 4)
Studying antibiotic use in a paediatric intensive care unit in
relation to the development of sepsis with Gram-negative
bacteria.
(chapter 6)
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CHAPTER ONE
Antimicrobial practice and 
malpractice in paediatrics
Marlies A. van Houten and Jan L.L. Kimpen
Reviews in Medical Microbiology
2000: 11(4); 189-195
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Abstract
Antibiotics are prescribed for a considerable proportion of paediatric
patients, often on an empirical basis without appropriate proof or
suspicion that a bacterial infection is present. This overuse and abuse
has a significant impact on both health care expenditure and
development of antibiotic resistance. However, little is known on the
mechanisms underlying prescribing patterns by physicians.
Pharmacoeconomic data on antibiotic use in paediatrics are lacking
and the correlation between prescribing patterns and resistance
development is only documented for a limited number of paediatric
infectious diseases. Unfortunately this information is indispensable
in order to design future strategies to control health care costs and
curtail resistance development.
Antimicrobial practice and malpractice in paediatrics
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Introduction
Antimicrobial agents are among the most frequently prescribed
drugs, in adults as well as in children.1,2 Since their discovery
antibiotics have changed considerably the epidemiology and
prognosis of bacterial infectious diseases. Complications of
frequent bacterial infections such as otitis media have become
uncommon, and the mortality and morbidity of severe
infections as meningitis and osteomyelitis have been reduced
considerably. Antibiotics have been considered miracle drugs
during the second half of this century and the number of new
agents that were developed in the decades following the
discovery of penicillin is striking. However, with an exhaustive
list of antibiotics available in the therapeutic armamentarium of
every physician, it becomes increasingly evident that in a
considerable proportion of cases antibiotics are prescribed
unnecessarily, an inappropriate agent is chosen, or the dose is
incorrect.3,4 In addition a tendency exists to prescribe newer,
more expensive, broad-spectrum drugs.5,6 Partly as a result of
these prescribing patterns costs involved in antibiotic usage are
exorbitantly high, especially when all related expenses are
taken in consideration (purchase of the drug, preparation and
administration by trained personnel).7 
More important however is the relation between the use of
antibiotics and the emergence of antimicrobial resistance.
Although the development of resistance is enhanced by a
number of factors including usage of antibiotics in animal
husbandry and over the counter use by patients, prescribing
patterns by physicians are probably a major determinant.
Although there is extensive literature on antibiotic policy in
adults, information concerning antibiotic use and its possible
consequences in the paediatric setting is scant. The present
review summarises the relevant literature on antibiotic
prescribing policy in relation to health economics and
development of resistance, with a focus on paediatric data.
Chapter one
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Use, overuse and abuse of antibiotics
The first studies on antibiotic use were performed in adults
admitted to general hospitals.8-10 It was shown that one third of
adults receive at least one course of antibiotics during one
hospitalization. It became clear from later studies that
antibiotic usage was even higher in paediatric and surgical
services. Young age and admission on an intensive care unit
were correlated with an increased tendency to receive
antibiotics. 11-14 We showed recently that in a tertiary care
hospital infants less than 2 years of age received significantly
more often antibiotics than older children (25 vs. 11% of all
admissions). Children admitted on neonatal or paediatric
intensive care units received more often antibiotics than
patients admitted on medium care wards (50 vs. 30%) as well
as more different courses (2.6 vs. 1.9 per patient per
hospitalization).13 Penicillins were prescribed most commonly,
followed by cephalosporins, aminoglycosides and macrolides.
More recently data have become available on the use of anti-
biotics in the outpatient setting. Although antibiotics have little
or no effect on viral conditions such as upper respiratory tract
infections and bronchitis, more than half of adult patients
suffering from these diseases are prescribed antibiotic treat-
ment.15 Another study showed that 25% of the population of
France was treated with antibiotics in 1991 (as compared to 17%
in 1980). In the meantime an increased prescription rate for
presumed viral conditions was demonstrated.16 Although the
methods used in the studies mentioned above differ considera-
bly. The conclusion is inevitable: antibiotics are prescribed on a
large scale both for hospitalised individuals and out-patients. 
The use of antibiotics in paediatrics has some peculiar aspects.
Children are especially prone to severe infections by micro-
organisms as S. pneumoniae, N. meningitidis and Salmonella
species. In the meantime the clinical presentation of a severe
bacterial infection can be misleading in the very young in
Antimicrobial practice and malpractice in paediatrics
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comparison with the clear-cut clinical picture in the older
patient. This implicates that certain forms of empirical
antibiotic therapy in unproven but suspected bacterial diseases
in childhood is legitimate, e.g. in febrile infants less than 3
months old, or children with meningitis and a negative Gram
stain of the cerebrospinal fluid. 
However, we cannot deny an unwarranted large-scale use of
antibiotics and a gradually increasing use of new, broad-
spectrum and expensive agents, suggesting overuse and
possibly abuse of these drugs.5,12,14,17,18 This malpractice can
take several forms (table 1). Treatment of non-bacterial or self-
limiting bacterial infections is common. Two recent reports in
the paediatric literature, using questionnaires mailed to
general practitioners and paediatricians, show that between 25
and 75% of patients with mild, probably viral, respiratory
infections receive antibiotics, especially if the course of the
disease is protracted for 7-10 days.6,19,20 Even so,non-infectious
diseases as asthma are often treated with a course of beta-
lactam or macrolide antibiotics.21 Finally, self-limiting bacterial
upper respiratory tract infections are often treated with
prolonged and repeated courses of antimicrobials, where
withholding antibiotics or using a shorter course might be an
Chapter one
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TABLE 1. Forms of overuse or abuse of antibiotics in clinical 
practice
¥ Treatment of non-bacterial diseases
¥ Treatment of self-limiting bacterial diseases
¥ Inappropriate antibiotic prophylaxis
¥ Treatment of ÒsuspectedÓ rather than proven infections
¥ Errors in generic choice, dosing and duration of therapy
¥ Inappropriate combination therapy
¥ Parenteral rather than oral therapy
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effective treatment option. Although it is clear that some cases
of otitis media and sinusitis deserve antibiotic therapy, in
order to prevent infectious complications this is clearly not
applicable to all patients. The majority of paediatric patients
with these diseases recover without antimicrobial treatment.
Delineating the complication-prone group is difficult and
guidelines on antibiotic treatment of these upper respiratory
tract infections should incorporate these uncertainties.22-24
More than half of the antibiotic courses prescribed for
hospitalised children are given on empirical grounds i.e.
without microbiologic or clinical proof of a bacterial infection
before or after the start of the antimicrobial treatment.13
Errors in generic antibiotic choice, dosing and duration of
therapy are unacceptably common. It has been estimated that
errors in prescription could be detected in 30% of medical and
60% of surgical cases both in adults and children.14,25 A
questionnaire containing 13 clear-cut clinical cases was sent to
paediatricians in the Netherlands and Belgium. Physicians
were asked to choose a generic antibiotic, as well as the dose
and duration of treatment. There was a complete lack of
uniformity in the three parameters of the questionnaire as
shown for one particular case (bacterial meningitis) in figure 1.
Between 25 and 50% of dosages and durations of therapy for
the various clinical conditions fell outside the range of
appropriate treatment. 26 Finally, inappropriate combination
therapy and parenteral rather than oral therapy induce
overuse of antimicrobial agents.27-29
Several reasons can be proposed to explain this manifest
overuse and abuse of antibiotics (table 2). Driven by previous
experience or litigation issues, physicians prescribe antibiotics
out of a feeling of insecurity, especially if the disease runs a
protracted course.20,21,30,31 PatientsÕ expectations, often against a
background of an established doctor-patient relationship, can
induce a culture of prescribing antibiotics for unclear
Antimicrobial practice and malpractice in paediatrics
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indications.32,33 Lack of in-depth knowledge of microbiologic
aspects of infectious diseases and of pharmacodynamics and
pharmacokinetics of antimicrobial medications induce a lack of
uniformity of prescription, especially in the absence of clear
local or international guidelines.26 Finally the impact of recent
trials in which the physician collaborated and aggressive
marketing by pharmaceutical companies cannot be ignored.34
This overuse (and abuse) of antibiotics is responsible for a
disproportionate expenditure of health care money in general
Chapter one
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FIGURE 1. The antibiotic choice of paediatricians and residents for a
child with bacterial meningitis. These results were part of a question-
naire, with 13 clear clinical cases, in which paediatricians and residents
were asked for their generic antibiotic choice for each of the cases.
28% penicillin/
chloramphenicol
5% small spectrum
penicillin
8%
unknown
1% aminoglycoside/chloramphenicol
7% penicillin/
aminoglycoside
16% third generation
cephalosporin
2% aminoglycoside/
second generation
cephalosporin
31% penicillin/
third generation
cephalosporin
2% aminoglycoside/
third generation
cephalosporin
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and hospital budgets in particular.5 Unfortunately scientific
literature on this correlation is almost non-existing.
Prescribing and resistance development
Widespread antimicrobial-drug resistance is one of the most
important challenges in medicine at the turn of the century.
Soon after the discovery and clinical application of antibiotics,
resistance of both community- and hospital-acquired micro-
organisms emerged. There is increasing doubt whether
development of new drugs can keep pace with the ability of
the bacteria to develop resistance. The mechanisms of
resistance are reviewed in detail elsewhere.35-37 For the
paediatric population especially pneumococcal resistance
against penicillin is cumbersome, as well as resistance of
Gram-negative microorganisms against beta-lactam anti-
biotics.38,39 Prior exposure of bacteria to antibiotics promotes
the development of resistant mutants. In this regard the
widespread use of antibiotics as growth-promoting agents in
cattle and fowl is a definite determining factor.40 A causal
relationship between antibiotic usage in clinical medicine and
development of resistance of microorganisms in hospitals has
Antimicrobial practice and malpractice in paediatrics
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TABLE 2. Reasons for overuse and abuse of antibiotics
¥ Feeling of insecurity (previous experience)
¥ PatientsÕ expectations
¥ Doctor-patient relationship
¥ Aggressive marketing by pharmaceutical companies
¥ Lack of uniformity among physicians in the same organisation
¥ Lack of knowledge of microbiologic aspects of infectious diseases
¥ Lack of knowledge on pharmacodynamics and pharmacokinetics
¥ Impact of recent clinical trials (Òseeding trialsÓ)
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been suggested on the basis of consistent associations between
the emergence of resistant strains and concurrent variations in
antibiotic use in populations over time.41 However, conclusions
of the studies can not be generalised to all drugs and all
patient populations because of the lack of uniformity in
defining resistance, variations in susceptibility of test methods
(and interpretation of the results), potential study selection
biases, and failure to control for confounding variables,
especially variations in infection control measures in the
hospital or extended care setting.42
Nonetheless, there are sufficient reports of the association
between antimicrobial usage both in the community and in
hospitals, and the emergence of antimicrobial resistance to
implicate prescription attitudes as a causal factor in
antimicrobial resistance development.43 A striking example
was reported in Finland where the overall use of erythromycin
nearly tripled from 1979 to 1989, followed by a rapid and
substantial increase in resistance to erythromycin in group A
streptococci.44,45 A similar example constitutes the increased
carriage rates of penicillin-resistant pneumococci following
increased individual antibiotic use and total antimicrobial
consumption in the population.46 Several studies show a
significant association between prior use of cephalosporins and
the development of resistant Gram-negative micro-organisms
which have become a major threat especially in intensive care
units.47-50 A survey of American hospitals reported by the
Centers for Disease Control and Prevention indicated a linear
increase in ceftazidime resistance among Klebsiella and
Enterobacter isolates after the use of cephalosporins, partic-
ularly in intensive care units and teaching hospitals, between
1987 and 1991.50 Also the use of the newer fluoroquinolones
has been followed soon by fluoroquinolone resistance.51
Although these studies constitute only a few examples of the
relation between antibiotic use and resistance development,
they are illustrative for the magnitude of the problem and the
necessity to take appropriate action on the local and global level.
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Future strategies 
The increasing costs accompanying overuse and abuse of
antibiotics, as well as the problem of antibiotic resistance have
made the necessity to design future strategies more urgent
than ever. These strategies will have to be focused on all
individuals involved in antibiotic consumption. Several
national and international societies have recognised this
challenge and taken action through the installation of task
forces 52, and general as well as specific guidelines are
proposed to control costs and slow down development of
antimicrobial resistance.43,53
First, patients themselves need to understand what antibiotics
can and cannot do. If antibiotics have been prescribed they
should take the complete course as accurate as possible. Self-
medication should be discouraged. Physicians and national
authorities have the responsibility to educate the population
about these issues, through mailings, symposia, broadcasting
or direct individual argumentation.
Second, use of antibiotics as growth-promoting agents in
animal husbandry should be discouraged and probably
banned. In the absence of clear evidence for their effect as
growth-stimulators and the global threat of resistance
development, laws should be passed to prohibit this practice.
Third, pharmaceutical companies have the responsibility to
concentrate on development of new agents rather than on
aggressive marketing campaigns.54 They should explore new
targets for antibacterial drugs and in concert with the scientific
community, design treatment strategies different from the
classic pathogen-specific drugs.55
Fourth, national governments and international political and
non-governmental organisations should stimulate research in
the area of resistance control and support initiatives to
implement stringent guidelines. Moreover, they should pass
Antimicrobial practice and malpractice in paediatrics
31
Binnenwerk Van Houten def  14-03-2001  11:54  Pagina 31
laws and recommendations enforcing agreed-upon results of
these initiatives to prevent overuse and abuse of drugs.
Fifth, physicians prescribing antibiotics, microbiologists
engaged in hospital epidemiology and resistance
surveillance, and hospital pharmacists evaluating the
antibiotic-related costs, play an important role. Although the
epidemic of antimicrobial resistance and the challenge of cost
containment are global problems, monitoring and
management need to be executed locally.56 As shown by
Seppl et al., changing the prescription of macrolide
antibiotics in Finland had a beneficial effect on the prevalence
of macrolide resistant Group A streptococcal isolates.44
Unfortunately, not all actions taken in this regard are as
successful, as has been shown for changing prescription
patterns of aminoglycosides.57,58 Most probably, preventive
strategies are more effective than actions taken after resistance
has developed. 59,60 Several plans can be developed to
streamline these preventive measures. Microbiologists and
(paediatric) infectious disease specialists need to have a
programmatic role in controlling antibiotic prescription
guidelines.61-63 Among the possibilities are strictly enforced
antimicrobial formularies, specific antibiotic order forms 64,65,
automated stop orders, computerised decision models for
empiric antibiotic selection 66, top-down manipulation and
enforcement of formularies 67, implementation of a Òprior
authorisationÓ model for selected drugs68, general
standardised antimicrobial prophylaxis guidelines 69,
automated cost reports and individual feedback mechanisms
controlled by the hospital pharmacy70, and educational
programs on the student and post-doctoral level. Each method
itself has its own advantages and disadvantages and until
now a study in which all these methods are compared has not
been performed. 
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Conclusion
Antibiotic use, overuse and abuse for clinical and outpatient
situations alike have driven antimicrobial-related costs to
disproportionate levels and can be implicated as important
promoters of development of antibiotic resistance. Since the
majority of diseases of childhood has an infectious origin,
paediatricians have contributed considerably to this
threatening situation. Strategies to curtail these events need to
be implemented soon in order to have a reasonable chance to
slow the pace with which we are moving towards the post-
antibiotic era.
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Abstract
Background ¥ In paediatrics antibiotics are among the most
commonly prescribed drugs. Because of an overall rise in health care
costs, lack of uniformity in drug prescribing and the emergence of
antibiotic resistance, monitoring and control of antibiotic use is of
growing concern and strict antibiotic policies are warranted. Before
such a policy can be implemented, detailed knowledge of antibiotic
prescribing patterns and related costs is important. In this study a
shift of antibiotic prescriptions patterns over time is described in
relation to hospital antibiotic expenditure.
Methods ¥ Over a 10-year period (1984 -1994) pharmacy surveys of
antibiotic costs in relation to prescription patterns in a paediatric
university hospital were analysed.
Results ¥ In 1984 small- and broad-spectrum penicillins represented
almost 50% of the total antibiotic expenditure, versus 7% in 1994. On
the other hand, the use of third generation cephalosporins and
vancomycin increased from 3.2% to 46.7% and 0.2% to 17.2% of the
total antibiotic costs respectively. The reasons for this shift in
prescribing pattern could only partially be explained by an increase
in admissions of Òhigh-useÓ patients or a shift in antibiotic resistance
patterns. Moreover, monitoring the antibiotic costs is only of limited
help in monitoring these prescription changes.
Conclusions ¥ A considerable shift in prescription patterns towards
more expensive and broader spectrum antibiotics occurs in
paediatrics, carrying a risk for the development of antibiotic
resistance among the most prevalent micro-organisms in this age
group. 
Keywords: children, antibiotics, drug expenditure, drug utilization,
prescriptions.
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Introduction
In children antibiotics are among the most commonly
prescribed drugs.1 Several studies focusing on antibiotic
prescribing attitudes in hospitalised children indicate that
approximately 35% of infants and children admitted to
hospitals receive antibiotics.2-5 Widespread misuse has been
reported. Almost half of all antibiotic prescriptions have been
found to be inappropriate, based on clinical and economical
criteria.6 Because of the rising costs in health care, lack of
uniformity in prescribing attitudes and the emergence of
antibiotic resistance, monitoring and controlling antibiotic use
is of growing concern.7-10 Several professional societies have
issued urgent statements to reduce the use of antibiotics
worldwide by means of strict local antibiotic policies.7,10 Before
such a policy can be implemented, detailed knowledge of
antibiotic prescription patterns and related costs is important.
Defined Daily Dose (DDD) can be used as a measure of drug
utilization in adults.11,12 Only one study described the use of
DDD in children.13 A combination of other, mostly indirect
variables, as expenditure and number of prescriptions of
antibiotics per patient or hospital day as well as recording all
adverse reactions to drugs are used more often.1-6,13
In this study the use of antibiotics in a tertiary care paediatric
university hospital over a 10-year period was evaluated, by
analysing the prescription patterns in relation to the total
antibiotic expenditure.
Methods
The study was performed in the Beatrix ChildrenÕs Hospital, a
Paediatric University Hospital in the Northern part of the
Netherlands. The hospital is the only tertiary referral centre for
a population of approximately 2.5 million. The number of beds
increased during the study period from 80 to 103. A 23-bed
Chapter two
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neonatal intensive care unit was built in 1984, followed by a 6-
bed paediatric intensive care unit in 1986. Annually
approximately 2000 patients are admitted for a mean duration
of hospitalization of 13.9 days. Over a 10-year period (1984-
1994) pharmacy surveys of antibiotic costs and prescriptions of
all inpatients were analysed. Antibiotics used were classified
according to the hospital formulary and the international
Anatomical Therapeutical Chemical (ATC)-classification.14
Additional information was collected from the financial
records of the ChildrenÕs Hospital. Total antibiotic expenditure
for each antibiotic class, general prescription patterns, price
changes and quantities of antibiotics used were investigated. 
Results
During the study period the prescription patterns changed
considerably. In 1984 penicillins represented almost 50% of the
total antibiotic expenditure and the aminoglycosides 23.2%. In
1994 these percentages had decreased drastically to 7.0% and
9.0% respectively. On the other hand, the use of
cephalosporins and vancomycin increased from 17.7% to 49.9%
and 0.2% to 17.2% of the total antibiotic costs respectively
(table 1).
The use of small- and broad-spectrum penicillins decreased
from 47.8% in 1984 to 2.9% in 1994, while in the same period
the use of combination penicillins (amoxicillin/ clavulanic
acid) increased from 0.4% to 4.1%. Looking at the different
generations of cephalosporins hardly any change was found
for the first generation. The second generation decreased from
13.6% to 2.6%, but the third generation cephalosporins
increased significantly during these 10 years, from 3.1% in
1984 to 46.7% in 1994. The antimycotic and antiviral drugs and
quinolones were prescribed increasingly during the study
period although changes were less dramatic. Other antibiotics
as macrolides, tetracyclines, polypeptides, sulphonamides,
Shift in antibiotic prescribing patterns
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were responsible for less than 10% of total antibiotic
expenditure and did not show a remarkable change during the
study period. Although several reasons can be suggested for
this shift in antibiotic expenditure, none of them is fully
explanatory. Major changes in resistance patterns did not
occur. Methicillin resistant Staphylococcus aureus and penicillin
resistant Streptococcus necessitating empirical vancomycin use
is an extremely rare event (less than 1%). Price fluctuations of
Chapter two
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TABLE 1. Use of antibiotics as percentage of total antibiotic expenditure
Antibiotics 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Penicillins
small-spectrum 8.2 4.7 3.0 2.6 3.0 3.1 2.2 1.4 1.0 1.5 0.7
broad-spectrum 39.6 36.9 21.8 14.4 9.7 6.7 4.1 2.6 4.1 2.8 2.2
combination 0.4 0.6 0.4 0.2 1.9 0.9 1.8 0.6 1.1 3.5 4.1
Total 48.2 42.2 25.2 17.2 14.6 10.7 8.1 4.6 6.2 7.8 7.0
Cephalosporins
first generation 0.9 0.5 0.7 0.3 0.4 0.5 0.2 0.2 0.3 0.4 0.3
second generation 13.6 11.4 5.7 9.2 9.4 10.7 16.0 11.3 11.1 5.9 2.6
third generation 3.2 15.0 40.0 33.0 26.5 23.2 18.0 21.7 23.0 42.6 46.7
Total 17.7 26.8 46.5 42.5 36.3 34.4 34.2 33.3 34.4 48.9 49.6
Vancomycin 0.2 1.5 2.2 4.8 7.0 10.1 20.0 19.4 21.1 15.0 17.2    
Amino-
glycosides 23.2 20.5 15.3 18.3 17.1 19.5 17.9 17.7 16.2 10.7 9.0    
Antivirals 0.1 0.1 0.0 1.6 2.7 5.7 3.3 3.8 6.0 5.4 4.4
Antifungals 2.8 2.2 2.4 6.3 8.5 9.4 6.9 10.0 6.6 4.1 5.6
Quinolones 0.0 0.0 0.0 0.1 3.6 1.5 1.5 1.7 0.0 0.3 0.4
Others 7.8 6.6 8.4 9.1 10.1 8.7 8.1 9.5 9.5 7.8 6.8
Total (%) 100 100 100 100 100 100 100 100 100 100 100
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antibiotics, used by pharmaceutical companies for marketing
purposes as well as by hospital pharmacies to reduce drug
costs, influence the crude expenditure figures considerably, as
illustrated in table 2. When calculating an average price for
prescribed antibiotics, the estimated antibiotic expenditure in
1994 would be nearly twice the expenditure in 1984 if the
prices had not decreased over the years. Although prices and
the number of prescription per patient decreased, the total
expenditure remained constant, mainly because of the use of
more expensive, broader spectrum drugs. If prices had not
changed over the years the estimated expenditure would be
doubled. 
Discussion
Until now no study in literature could be found describing
shifts in prescribing patterns of antibiotics in paediatrics. Over
the study period a dramatic shift in antibiotic prescription
patterns was observed, although the total antibiotic
expenditure did not increase significantly. A remarkable shift
occurred from the use of less expensive penicillins to newer,
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TABLE 2. Estimation of expenditure in 1994 with constant number of 
prescribed units of antibiotics
Year 1984 1994
Total antibiotic expenditure (U.S.dollars) 278615.4 285031.4
Number of prescribed units antibiotics 46851 23598
Average price of antibiotics 5.9 11.9
Estimated expenditure with constant
number of prescribed units antibiotics 557526.9
Estimated expenditure with constant price 140333.5
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resistance inducing and more expensive cephalosporins and
vancomycin.15 This could not be explained by shifts in
resistance patterns of isolated micro-organisms. A
remarkable increase in the number of admissions or
hospitalization days did not occur, although a shift to a
higher intensity of medical care could not be ruled out.
Over the study period a slight increase in number of
admissions of Òhigh-useÓ patients could be found. The
number of patients admitted yearly to the neonatal
intensive care unit increased gradually from 408 in 1984 to
604 patients in 1994. Of these admitted neonates the
percentage of mechanically ventilated patients remained
50% over the years and the number of patients with an
umbilical catheter which is a possible entrance for micro-
organisms decreased from 50% in 1984 to less than 15%of all
admitted patients in 1994. The number of patients admitted
to the paediatric intensive care unit increased from 193 in
1986 to 289 patients in 1994. Next to these data an increase
in the number of admitted oncology patients receiving
antibiotics could be shown from 299 in 1984 to 367 patients
in 1994. The influence of new antibiotic protocols is
marginal and compensate each other mutually. 
The total costs of antibiotics is often used by hospital boards
to monitor budgets and motivate personnel for a change in
prescribing attitudes. It is shown that due to several factors
as marketing techniques and price cuts, this parameter is
useless for monitoring antibiotic use in the hospital. It is
necessary to study prescription patterns of antibiotics over
several years, in order to study clinically, economically and
microbiologically important shifts and relate these
prescription patterns to shifts in the patient populations.
More accurate indicators as DDD per 1000 hospital days
should be used, but this parameter is only practical in adult
medicine. To our knowledge no equivalent accurate
parameter exists for children.
Chapter two
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Abstract
Background ¥ Antibiotics are among the most commonly prescribed
drugs in paediatrics. Most frequently antibiotics are started
empirically. Lack of uniformity in prescribing attitudes causes
uncontrollable expenses for antibiotic treatment and is at least
partially responsible for the emergence of antibiotic resistance. The
objective of this study was to assess the agreement on empiric
antibiotic selection between paediatricians.
Materials and methods ¥ A questionnaire including 13 hypothetical
clinical cases was sent to all paediatricians and paediatric residents in
the northern part of the Netherlands, and a random selection of
paediatricians of Flanders, the northern part of Belgium. Their choice
of antibiotic therapy (generic class, dose, duration) with regard to
these cases was evaluated. 
Results ¥ One hundred and seven (68.6%) of 156 Dutch
paediatricians and paediatric residents returned completed
questionnaires. Thirty-six (36%) of 100 Belgian paediatricians
returned completed questionnaires. A widespread variability in
choice of antibiotic therapy was found, especially in the generic class
of the antibiotic. A median of 17 and 11 different antibiotics for the
Dutch and Belgian paediatricians respectively was found per clinical
case. The greatest variability (32 and 17 different antibiotics for the
Dutch and Belgian paediatricians respectively) was found for a
premature infant with suspicion of bacteraemia. The lowest
variability existed for cases with lower respiratory tract infections
and otitis media (5 and 3 different antibiotics for the Dutch and
Belgian paediatricians respectively). In addition the dose of the
antibiotic and duration of treatment varied considerably. A
disturbing proportion of doses was not in concert with commonly
advised regimens.
Conclusion ¥ Considerable variability was found in empiric
antibiotic selection between paediatricians and paediatric residents in
Empiric antibiotic therapy
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The Netherlands and Flanders. In order to reduce antibiotic costs and
limit antibiotic resistance development, one of the first goals will be
to increase uniformity in antibiotic prescribing attitudes.
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Introduction
In children antibiotics are among the most commonly
prescribed drugs.1 Several studies focusing on antibiotic
prescribing attitudes in hospitalised children indicate that
approximately 35% of infants and children admitted to
hospitals receive antibiotics.2-5 Most frequently antibiotics are
started on an empirical basis, defined as treatment without
clear clinical or microbiological evidence of infection.6
Antibiotic selection has become more difficult with the recent
release of many agents with various pharmacokinetic,
antimicrobial and toxicological characteristics and the
emergence of resistance to many traditional agents.7
Widespread misuse of antibiotics has been reported. Almost
half of all antibiotic prescriptions have been found to be
inappropriate, based on clinical and economical criteria.8
Serious consequences in terms of mortality and complications
can result from inappropriate antibiotic therapy.9 Because of
the rising costs in health care, lack of uniformity in prescribing
attitudes and the emergence of antibiotic resistance,
monitoring and controlling antibiotic use is of growing
concern.10-13 Therefore worldwide attempts have been made to
optimise the use of antibiotics. Several professional societies
have issued urgent statements to reduce the use of antibiotics
worldwide by means of strict local antibiotic policies.12,13 In the
Netherlands the ÒHealth CouncilÓ stressed the importance of
an optimal use of antibiotics based on data obtained by regular
surveillance of bacterial resistance patterns.14 In 1991 75% of
the Dutch university hospitals and 53% of the hospitals with
500 beds or less had written guidelines, but these formularies
require further improvement and need revision.15 Since 1995
an independent formulary for paediatrics has been used most
commonly for the treatment of infectious diseases in the
Netherlands.16 In order to implement an antibiotic policy it is
important to determine the existence of uniformity in antibiotic
prescribing attitudes for in- and outpatients. Although
Empiric antibiotic therapy
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consensus reports on the treatment of individual infectious
diseases are available, large variability exists in therapeutic
practice on the local, national and international level.17-20 On
the other hand it has been shown that compliance with a
strictly enforced antibiotic regimen leads to reduction of costs
and resistance development.21,22 In order to study the degree of
uniformity of empiric antibiotic therapy in paediatrics
questionnaires with clinical cases was sent to all paediatricians
and paediatric residents in the northern part of the
Netherlands and Flanders.
Methods
Questionnaires were sent to all 156 paediatricians and
paediatric residents in the northern part of the Netherlands
and to 100 randomly selected paediatricians in Belgium. In the
Netherlands sixty-seven are working in one university
hospital, 89 divided over 25 regional hospitals. Each fifth
paediatrician on an alphabetical list of all Flemish
paediatricians was selected up to a total of 100 practising
paediatricians. Initial non responders received up to two
additional mailings of the same questionnaire. The
questionnaire contained 13 clear clinical situations; a child of
three weeks old with bacterial meningitis (1), a four year old
girl with a clinically and radiologically proven bacterial
pneumonia (2), a seven year old boy with sinusitis (3), a five
year old girl with pyelonefritis (4), a four year old child with
bilateral otitis media (5), a premature infant, with respiratory
distress and sepsis (6), a twelve year old girl with high fever,
hypotension, tachycardia and bloody diarrhoea (7), an eight
year old boy with osteomyelitis of the ankle (8), an eight year
old girl with atypical pneumonia (9), a three year old girl with
bacterial meningitis (10), a four year old girl with endocarditis
(11), a two year old girl with infected eczema (12) and a nine
year old boy with septic arthritis (13). For each of these cases
Chapter three
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an empirical antibiotic treatment was requested including
generic name of the drugs, as well as dose and duration of
treatment. Missing answers (because the respondent indicated
he did not know the empirical treatment) were excluded from
further analysis. Questionnaires were analysed for each case
separately. For each case the number of different selected
antibiotics (that means the number of generic groups and the
number of antibiotics as part of the same generic group), as
well as the variability in dose and duration of therapy was
analysed. The degree of variability was empirically classified
in three groups: greatest variability (< 2 doctors per choice),
less variability (> 5 doctors per choice) and average variability
(>2 and < 5 doctors per choice). Data were analysed for all
paediatricians and for the Dutch paediatricians (in the
university setting and regional setting) and Belgian
paediatricians separately. The survey was conducted
anonymously.
Results
In the Netherlands 30 paediatricians (71%) and 20 paediatric
residents (80%) of the university hospital and 62 paediatricians
(69.7%) of the community hospitals returned questionnaires, of
which 107 (68.6%) were completed and 5 (3%) were returned
without any answers. In Belgium 38 paediatricians (38%)
returned questionnaires, of which 36 (36%) were completed
and 2 (2%) were returned without any answers. A great
variability in choice of antibiotic therapy was found, as shown
in table 1 for each case. Looking at the different generic drugs
even less uniformity in choice could be found (data not
shown). For residents the greatest variability was found for the
cases with central nervous system infections and endocarditis;
for paediatricians in the university setting for the cases with
suspicion of meningitis, pyelonefritis, and bacteraemia; for
paediatricians in the regional setting for the child suspected of
Empiric antibiotic therapy
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endocarditis and for the Belgian paediatricians for the cases
with suspicion of bacteraemia or endocarditis. The least
variability was found for the residents for the cases with
respiratory tract infections and pyelonefritis; for the
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TABLE 1. Number of antibiotic classes chosen for each case
(The following antibiotic classes were defined: penicillins, cephalosporins,
aminoglycosides, sulphonamides, vancomycin, quinolones, metronidazol
or a combination of these antibiotics)
The chosen number of antibiotics / the exact number of respondents for
each individual case. When the answer ÒunknownÓ was selected, this was
considered a missing value and excluded for further analysis.
Case Residents Paediatricians Paediatricians Total Paediatricians
number University University Community Netherlands Belgium
hospital hospital hospital
(n = 20) (n = 30) (n = 62) (n = 112) (n = 36)
1. 5 / 19 4 / 26 4 / 59 5 / 104 6 / 34
2. 1 / 19 3 / 28 4 / 59 4 / 106 4 / 36    
3. 2 / 17 2 / 27 4 / 59 4 / 103 3 / 36    
4. 2 / 17 6 / 25 6 / 59 8 / 101 7 / 36    
5. 2 / 19 2 / 28 3 / 59 3 / 106 5 / 36     
6. 4 / 20 7 / 25 6 / 59 7 / 104 6 / 33    
7. 8 / 15 11 / 21 11 / 53 15 /  99 10 / 34   
8. 3 / 16 4 / 27 6 / 56 6 /  99 5 / 36     
9. 2 / 17 3 / 26 4 / 56 5 /  99 5 / 36   
10. 7 / 20 4 / 27 8 / 58 9 / 105 5 / 35  
11. 5 / 13 5 / 18 6 / 38 8 /  68 7 / 25  
12. 5 / 15 5 / 26 6 / 55 7 /  96 5 / 36  
13. 3 / 13 4 / 23 4 / 52 4 /  88 4 / 31  
mean: 3.8 ± 2.1 4.6 ± 2.4 5.5 ± 2.1 6.5 ± 3.1 5.5 ± 1.8
range: 1 Ð 8 2 - 11 3 - 11 3 - 15 3 - 10
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paediatricians in the university setting for the cases with
respiratory tract infections; for paediatricians in the regional
setting for the children suspected of respiratory tract infections
and for the Belgian paediatricians for the cases with
respiratory tract infections. Average variability was found for
all the rest of the cases. The dosage of the chosen therapy
showed also a considerable variability and did not always
comply with the literature or commonly used formularies16,23
(table 2). 
For both groups, the Dutch and Belgian paediatricians,
greatest variability was found in the dosage of penicillins for
central nervous system infections in a range between 13-500
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TABLE 2. Dosage of antibiotic therapy (milligrams/kg)
Antibiotic Dutch Belgian 
(infectious diseases; case number) Paediatricians  Paediatricians
range median range median
Penicillins (central nervous system
infections; 1 , 6, 7 and 10) 13 - 500 100 25 - 300 100
Penicillins (respiratory tract
infections; 2, 3, 5 and 9)
Oral 10 - 100 50 12.5 - 250 50
Intravenous 50 - 200 100 30 - 200 100
Cephalosporins (central nervous system
infections; 1, 6, 7 and 10)
Ceftriaxone 40 - 150 100 30 - 150 100
Ceftazidime/cefotaxime 50 - 300 100 50 Ð 200 100
Cephalosporins (pyelonefritis) 50 - 150 100 50 Ð 200 100
Aminoglycosides
Gentamycin/netilmycin/tobramycin 2 - 10 5.0 3 - 8 6.0
Amikacin 5 - 20 10.0 5 - 20 15.0 
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milligrams/kg and 25-300 milligrams/kg respectively. Only
26% of the amoxicillin prescriptions were between the
accepted range in dosage (200-400 milligrams/kg) as described
in textbooks of paediatrics. In the Netherlands a child with
suspicion of respiratory tract infections was treated
intravenous or orally with a dosage of penicillins between 50
and 200 milligrams/kg and 10 and 100 milligrams/kg
respectively. More than 75% was treated with a dosage as
suggested in textbooks of paediatrics. In Belgium these data
are comparable. 
The dosage of the aminoglycosides netilmycin, gentamycin
and tobramycin was too low or too high in 23% and 10% of
prescriptions in the Netherlands and Flanders respectively. For
Chapter three
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TABLE 3. Duration of therapy for each case
Case Dutch Paediatricians Belgian Paediatricians
number No. of days No. of days
range median range                 median
1. 7 - 21 14 3 - 21 10    
2. 5 - 14 10 5 - 14 8    
3. 5 - 14 7 5 - 21 10    
4. 5 - 21 10 3 - 14 10    
5. 5 - 10 7 5 - 14 8    
6. 5 - 21 10 5 - 14 10    
7. 5 - 14 10 5 - 10 7    
8. 7 - 42 28 5 - 42 21    
9. 3 - 14 10 3 - 21 10  
10. 7 - 21 10 3 - 14 10  
11. 10 - 42 42 6 - 42 28  
12. 5 - 28 7 5 - 14 8  
13. 3 - lifelong - 1 - lifelong -
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central nervous system infections, 60% and 70% of all children
were treated with a dosage of ceftriaxone according to the
advised regimen in literature. Forty and thirty percent were
treated with a low dosage. For ceftazidime and cefotaxime 90%
and 52% respectively were treated with correct dosages.
Finally the suggested duration of therapy showed a
remarkable variability for both groups (table 3). Again
generally accepted guidelines were breached in several
occasions.
Discussion
Considerable variability was found in empiric antibiotic
therapy between paediatricians and paediatric residents in the
northern part of the Netherlands and part of Belgium. A slight
difference exists between the choices of the paediatricians in
the Netherlands and Flanders. The clinical relevance of these
differences is not exactly clear, but the low response rate of the
Belgian paediatricians could have accounted for part of the
difference. This variability was evident for selected antibiotic
groups, generic classes of antibiotics as well as for dose and
duration of therapy. Although the data were derived from
written case simulations, which are not always predicting
physicians actual behaviour, the cases are clear,
straightforward and common.24 Highest variability was found
for central nervous system infections and lowest variability for
respiratory tract infections. This contrasts with the literature
suggesting more agreement in the therapy of central nervous
infections than for respiratory tract infections in children. For
the purpose of this study we were more interested in the (lack
of) agreement among doctors than in the scientifically correct
choice of antibiotics. However for most infectious diseases a
correct drug was chosen, the selected treatment was not often
appropriate as far as duration of treatment or doses was
concerned. In order to optimise patient care, to achieve a
Empiric antibiotic therapy
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reduction in health care costs and to reduce the emergence of
drug resistance, antibiotics should be used rationally.
Therefore an urgent need for a more appropriate selection and
use of antibiotics exists.11-13 In recent years treatment of
numerous infectious diseases has undergone several changes
and the question remains if there is a ÒbestÓ antimicrobial
therapy for each of these.25 Both in the presence and absence of
consensus reports on treatment of individual infectious
diseases, considerable variability exists in therapeutic practice
on the local, national and international level. 17-20 The duration
of treatment of numerous infectious diseases is also
controversial and no data from comparative studies are
available to suggest the best duration of therapy. The 7-10-14
day rule has been followed for most cases.19,20 Most clinicians
want to safeguard their autonomy in antibiotic prescription
and are only reluctantly willing to comply with strict
guidelines, although these strictly enforced regimens may lead
to a reduction of overall antibiotic use, costs as well as
resistance development.21,22 Best method to decrease antibiotic
costs as well as development of antibiotic resistance will be to
lower the use or prescription of antimicrobial drugs. Clear
formularies are warranted for optimal clinical decision
making, resulting hopefully in the choice of the best available
product at an adequate dose for a reasonable period of time.11-
13 The formulary should be based on the knowledge of local
trends in antimicrobial resistance. Enforcing the guidelines of
the formulary should be accompanied by a continuous
feedback for all prescribers, in which infectious disease
specialists and hospital epidemiologists have a central role.
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Abstract
Background ¥ Antibiotics are among the most commonly prescribed
drugs in paediatrics. Because of an overall rise in health care costs,
lack of uniformity in drug prescribing and the emergence of anti-
biotic resistance, monitoring and control of antibiotic use is of
growing concern and strict antibiotic policies are warranted. Before
such policy can be implemented, detailed knowledge of antibiotic
prescribing patterns is important.
Methods ¥ In this study the utilization of antibiotics in a paediatric
university hospital over 3 consecutive years has been analysed. Over
an 8-week period (1 november-22 december) in 1994, 1995 and 1996
patient charts were reviewed with regard to antibiotic prescription
(generic class, dose, duration and indication).
Results ¥ A total of 1120 patients were admitted during the study
periods. Antibiotics were prescribed at least once for 36% of
hospitalised children, although only 12.3% of the patients receiving
antibiotics had a proven bacterial infection. Thirteen, 4.7, 2.6, and
2.7% of all children received 2, 3, 4 or more than 4 antibiotics
respectively during a single hospitalization.
Infants less than 2 years are receiving more frequently antibiotics
than the older children (25% and 11% respectively, p = 0.0256).
More children admitted to the intensive care unit received antibiotics
compared to patients admitted on medium care. (49.7% and 29.3%
respectively, p < 0.0001). Likewise they received more often several
different antibiotic courses (2.6 courses per patient versus 1.9 courses
per patient, p < 0.0001). These children also received more often
intravenous compared with oral antibiotics (p < 0.0001).
Significant differences could be found between the generic classes
of antibiotics prescribed to children admitted to the intensive care
unit and the medium care. However high variability in dose and
duration of antibiotic therapy for the same clinical indication was
shown.
Antibiotic utilization for hospitalised paediatric patients
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Conclusions ¥ A high percentage of all hospitalised children received
antibiotics. In most cases antibiotics are started on an empirical basis,
without proof of a bacterial infection, nor before the start of therapy
neither afterwards. The fact that especially children admitted to
intensive care units and patients of younger age groups are at risk of
receiving multiple courses of antibiotics, together with the
knowledge that antibiotic resistance develops in the same setting,
suggest that strategies to control antibiotic use should focus on these
patient populations.
Keywords: children, antibiotics, drug utilization, and prescriptions.
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Introduction
Antibiotics account for a substantial proportion of the
expenditures in pharmacies and hospitals. In children
antibiotics are among the most commonly prescribed drugs.1
Several studies at the end of the 1970Õs focusing on antibiotic
prescribing attitudes in hospitalised children, indicate that
approximately 35% of admitted infants and children receive
antibiotics.1-6 Naqvi et al found a mean age of 5.6 years in their
study among 295 patients receiving antibiotics.1 Most studies
showed a comparable mean age, only one study found the
highest percentage of antibiotic prescription between 6 months
and 1.5 years of age.7 Widespread misuse has been reported.
Almost half of all antibiotic prescriptions have been found to be
inappropriate, based on clinical and economical criteria.8,9
Because of the rising costs in health care, lack of uniformity in
prescribing attitudes and the emergence of antibiotic resistance,
monitoring and controlling antibiotic use is of growing
concern.10,11 Although there has been a tremendous increase of
available products over the last 15 years, to our knowledge
only one recent study has reported the antibiotic use in paedia-
tric hospitalised patients.7 On the contrary, several professional
societies have issued guidelines designed urgent statements to
reduce the use of antibiotics worldwide by means of various
control strategies.12-15 Before such policies and measures can be
implemented, detailed knowledge of antibiotic prescription
patterns is important. Defined Daily Dose (DDD) can be used
as a measurement of drug utilization in adults.16,17 Only one
study described the use of DDD in children.17 A combination of
other mostly indirect variables, as expenditure and number of
prescriptions of antibiotics per patient or hospi-tal day as well
as recording all adverse reac-tions to drugs are used more
often.1-6 This study analysed the utilization of anti-biotics in a
paediatric hospital over three consecutive years (1994-1996),
with special regard to antibiotic prescription atti-tudes and
patterns (generic class, dose, duration and indication).
Antibiotic utilization for hospitalised paediatric patients
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Methods
This retro- and prospective study was performed in the Beatrix
ChildrenÕs Hospital, a Paediatric University Hospital in the
northern part of the Netherlands. It is a hospital with 105 beds
including 6 paediatric intensive care beds and 23 neonatal
intensive care beds. It is the only tertiary referral centre for a
population of approximately 2.5 million. Over an 8-week
period (1 November - 22 December) in 1994, 1995 and 1996 all
hospitalised patients were analysed for antibiotic use. Data
were collected by using discharge letters, as well as daily visits
of all paediatric services to screen patients for antibiotic use.
Nursing and medical records were analysed for patient
characteristics (age, gender, hospital department and number
of hospital days), the number of antibiotics for each patient
and the generic class, dose and duration of each antibiotic
prescription. Most of the medical files could be used to obtain
information on the indication of antibiotic prescription.
Antibiotic therapy was defined to be prescribed for a definite
infection, empiric without clinical or microbiological proof of
infection or prophylaxis. An infection was considered definite
when clinical signs (e.g. abscess), radiological evidence (e.g.
infiltrate on chest X-ray, osteolytic lesion with systemic signs
of infection) or microbiological tests (positive bacterial cultures
of otherwise sterile body fluids) made infection most likely.
Empiric therapy was defined as antibiotics administered in the
presence of clinical features suggestive of infection but absence
of localising signs or focus or microbiological confirmation.
Prophylaxis was defined as the use of antibiotics for
preventing infections e.g. before an operation or in certain
immunocompromised patients. Data were collected and
described for each year separately and for the 3 years together.
To assess statistical significance between data FisherÕs exact
test and unpaired t-tests were used where appropriate. A p-
value equal or less than 0.05 was considered significant.
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Results
A total of 1120 patients was admitted during the study period,
of which a mean of 36% received at least one course of
antibiotics during their hospitalization. In 1994, 1995 and 1996
these percentages were 33.3%, 40.5% and 33.7% respectively.
One hundred and eighty-three (49.7%) of 368 patients
admitted on the intensive care unit received antibiotics versus
220 (29.3%) of 752 patients on medium care units. (p < 0.0001).
The highest number of prescriptions was found in the
youngest age group of the study population, of which a high
proportion was admitted to the intensive care units. Infants
less than 2 years are receiving more frequently antibiotics than
the older children (25% and 11% respectively, p = 0.0256) Of
the 403 patients receiving antibiotics 229 (56.8%) were boys
and 174 (43.2%) girls. The median number of hospital days of
children receiving antibiotics was 14 days (range 1-260 days)
versus 13 days (range 1-377 days) for admitted patients not
receiving any antibiotic. For all hospitalised patients receiving
antibiotics no difference in number of prescribed antibiotics
between the three consecutive years could be found, the
Antibiotic utilization for hospitalised paediatric patients
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TABLE 1. The route of administration of prescribed antibiotics for
children admitted to the intensive care unit and on the medium care in
percentage of total antibiotic prescriptions on these departments
(The route of administration of 11 prescriptions was missing.)
Intensive Care unit Medium Care unit
(n = 436) (n = 409)
Oral 19 (2%) 185 (22%) 204 (24%)  
Intravenous 417 (49%) 224 (27%) 641 (76%)  
Total 436 (52%) 409 (48%) 845 (100%)
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average number of antibiotics per admission in 1994, 1995, and
1996 was respectively 2.0, 2.4 and 2.1. Only 1 antibiotic course
was prescribed in more than 35% of all prescriptions, 2
antibiotic courses were prescribed in 35% of all prescriptions, 3
antibiotic courses in 13% of all prescriptions, 4 antibiotic
courses in almost 7% of all prescriptions and finally 5 or even
more than 5 antibiotic courses were prescribed in about 8% of
all prescriptions. There is a significant difference between the
number of courses prescribed to children on the intensive care
unit (2.6) and the number of courses prescribed to children on
the medium care (1.9). (p < 0.0001) Also a significant difference
could be found between the route of administration of
antibiotics prescribed for children on the intensive care unit
and children on the medium care shown in table 1, 
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TABLE 2. Generic classes of prescribed antibiotics for children admitted
to the intensive care unit and on the medium care in percentage of total
antibiotic prescriptions on these departments and the corresponding 
p-values between these percentages
Generic classes Percentage of antibiotic prescriptions
of prescribed in percentage of all prescriptions
antibiotics
Intensive Care unit Medium Care unit
(n = 441) (n = 415) p-value
Penicillins 33% 27% p = 0.0546  
Cephalosporins 16% 16% N.S.  
Aminoglycosides 31%* 11% p < 0.0001  
Macrolides 2% 7%* p = 0.0005  
Vancomycin 9%* 5% p = 0.0106  
Sulphonamides 1% 20%* p < 0.0001  
Others 8% 14%* p = 0.0020
(* means a significant difference between the two percentages)
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of 11 prescriptions the route of administration could not be
found. (p < 0.0001) No significant difference in duration of oral
prescribed antibiotics and intravenous prescribed antibiotics
could be found. Many classes of antibiotics were prescribed as
shown in table 2. A significant difference between most
prescribed antibiotic classes on the intensive care unit and
medium care could be found. Looking at the indication of
prescribed antibiotic therapy, almost 60% of all prescriptions
were started empirically, almost 30% as prophylaxis and only
12.3% of all prescriptions for a definite infection. Most
commonly antibiotics were prescribed in case of a suspicion of
bacteraemia, followed by the diagnoses of respiratory tract
infections and neonatal infections or intrauterine infections.
Inter-doctor variability existed for daily prescribed doses as
well as for the duration of an antibiotic course. Table 3
illustrates the variability in daily prescribed doses of most
frequently prescribed antibiotics. No difference in mean
duration of prescribed antibiotics could be found between the
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TABLE 3.  The variation in prescribed dose of mostly prescribed
antibiotics for several infectious diseases
Antibiotic range median
(mgs/kg/day) (mgs/kg/day)
Penicillins (central nervous infections) 7.0 - 250 72.5
Penicillins (respiratory tract infections)
Oral 10.7 - 111.1 48.0
Intravenous 42.9 - 205.1 100.0
Cephalosporins 19.5 - 200 107.1
Aminoglycosides
Gentamicin/netilmicin/tobramycin 0.5 - 12.1 4.9
Amikacin 3.6 - 39.5 10.0
Vancomycin 5.0 - 74.3 40.3
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intensive care unit and the medium care, (5.7 days (range 1-23)
versus 5.9 days (range 1-57)).
Discussion
In this study a high percentage of all hospitalised children
receive antibiotics. Over 50% of all antibiotic prescriptions
were started on an empirical basis, without confirmation of a
bacterial infection. Especially children admitted to intensive
care units and young children are at risk of receiving multiple
courses of antibiotics. Several methods are available to study
antibiotic use in paediatric hospitals.1-7,18 In this study attention
was focused on the characteristics of the population receiving
antibiotics. Moreover the indication of antibiotic prescription
was studied. Our results are comparable with data found in
studies reported in the literature, performed more than 15
years ago.1-6 Until now no studies have been published on the
difference of antibiotic prescriptions on different paediatric
units. In our study a significant difference could be found in
percentage of antibiotic prescriptions and the route of
administration (more intravenous antibiotics in the Intensive
Care unit) for children admitted to the intensive care unit
compared with patients admitted on the medium care.
(p<0.0001) Likewise a significant difference in number of
antibiotic courses could be found between the former and
latter group. (p<0.0001) The highest number of antibiotic
prescriptions was made for children in the youngest age group
(between 0 and 2 years). Most antibiotics were prescribed on
an empirical basis. No uniformity in dose and duration of
antibiotic therapy was found. In 1995 a general hospital
formulary was introduced including the treatment of
infectious diseases in children, but this was not used very
often. More commonly old regimens have been followed.
During the study period new guidelines for the treatment of
neonatal sepsis and meningitis and new guidelines for
Chapter four
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oncology patients with fever and neutropenia were
introduced. Because of these a shift in the use of certain classes
of antibiotics was observed. Overall we may conclude that
over the study period a shift to the use of more expensive and
broader spectrum antibiotics was seen for all groups. 
Nowadays we are dealing with large problems of rising health
care costs and the emergence of antibiotic resistance.10 Some
recently performed studies showed an association between the
prior use of antibiotics and the development of resistance.19-22
Because of these emergent threats it is necessary to be
informed continuously about the use of antibiotics in the
hospital. Several professional organisations like the Infectious
Disease Society of America or the American Medical
Association stimulate or promote a more prudent use of
antibiotics.11,12,23 For example they recommended for each
hospital a committee to monitor antibiotic use and it should
provide guidance to the prescriber on good antibiotic
practice.24 The use of high-cost, specialized antimicrobial
agents should be a privilege of infectious disease consultants
and others trained in their use, just as performance of invasive
procedures are limited to those who are qualified.11 The
infectious disease community must work in concert with the
pharmaceutical industry to achieve a more optimal use of
antibiotics. Methods should based on education about
appropriate antibiotic use, hospitalÐbased programmes,
susceptibility testing and most important restricted use should
be warranted.11
Antibiotic utilization for hospitalised paediatric patients
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CHAPTER FIVE
Changing prescribing behaviour
after introduction of an antibiotic
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Abstract
Background ¥ Antibiotics are among the most commonly prescribed
drugs in children. Selection of the appropriate drug has become more
difficult with the release of an increasing number of agents, causing a
lack of uniformity in prescription attitudes of paediatricians.
Unfortunately this prescription attitude probably facilitates the
development of antibiotic resistance.
In this study an antibiotic formulary was introduced after intensive
monitoring of antibiotic use in daily practice. The level of uniformity
in empiric antibiotic therapy of paediatricians was analysed and
compared with the level of uniformity reported in our earlier
studies.18,19 In addition, general knowledge about antibiotics was
assessed.
Methods ¥ The study was conducted in a tertiary paediatric teaching
hospital. An authorised antibiotic formulary with empiric antibiotic
therapy for most common diseases in paediatrics was introduced.
Two months later a questionnaire including 13 hypothetical clinical
cases was sent to all paediatricians and paediatric residents in the
hospital. Their choice of antibiotic therapy (generic class, dose,
duration) with regard to these cases was evaluated. Simultaneously
the utilization of antibiotics in the hospital was analysed. Patient
charts were reviewed with regard to antibiotic prescription (generic
class, dose, duration and indication). Finally forty-five paediatricians
were asked to participate in an interview. The interview consisted of
an oral questionnaire focused on different characteristics of
antibiotics.
Results ¥ After the introduction of the formulary a significant
improvement in uniformity in antibiotic choice for theoretical cases
could be found compared with data found in our earlier studies.
However such a shift could not be found in the actual use of
antibiotics in daily practice. A high variability in chosen dosage and
duration of antibiotic therapy could still be shown. The interview
showed that the knowledge on the expected efficacy of an individual
Changing prescribing behaviour
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agent for a particular disease ranged from 13 to 63% depending on
the case. Most physicians (58%) could give a reasonable estimate of
the price. The pharmaceutical manufacturer was not known by more
than 80% of interviewees. Adverse reactions were known by 30% and
97% of interviewees, depending on the antibiotic. Only a few of the
paediatricians could give a correct answer about the resistance
pattern of the antibiotics.
Conclusions ¥ A very high percentage of prescribing paediatricians
was not familiar with characteristics of most commonly prescribed
antibiotics in current practice. The introduction of an authorised
antibiotic formulary solely is not enough to achieve a significant
change in antibiotic prescribing behaviour in a hospital, although it
can induce a learning effect.
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Introduction
Antibiotics are among the most commonly prescribed drugs in
paediatrics.1 Several studies focusing on antibiotic use in
hospitalised children indicate that approximately 35% of
infants and children admitted to hospitals receive antibiotics.2-5
Most frequently antibiotics are started on an empirical basis,
defined as treatment without clear clinical or microbiological
evidence of infection.6 Antibiotic selection has become more
difficult with the increasing release of many agents with
various pharmacodynamic, antimicrobial and toxicological
characteristics and the emergence of resistance to many
agents.7 Widespread misuse of antibiotics has been reported.
Almost half of all antibiotic prescriptions have been found to
be inappropriate, based on clinical and economical criteria.8
Serious consequences in terms of mortality and complications
can result from inappropriate antibiotic therapy.9 
The appropriateness of treatment decisions of physicians is a
recurrent issue in health care research.10,11 It has been assumed
that a lack of knowledge is the main determinant of
suboptimal clinical decision making.12 Many studies have
shown that traditional continuing education programs in the
usual lecture format do not result in long-term changes in
knowledge, competence or quality of care.13,14 Professional
behaviour in delivering health care is influenced not only by
knowledge but also by skills, attitudes, the health care system
and the behaviour of patients. An improvement in physician
prescribing behaviour could only be achieved by a
combination of strategies as described by Plumridge.15,16,17
In this study an authorised antibiotic formulary was
introduced. Soon after the introduction of this formulary a
detailed study of the effect on uniformity in choice of empiric
antibiotic therapy and the use of antibiotics in daily clinical
practice was analysed. Finally we showed an analysis of the
familiarity of paediatricians with most commonly prescribed
antibiotics in daily practice.
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Methods
The study was performed in the Beatrix ChildrenÕs Hospital, a
tertiary care paediatric department in the northern part of the
Netherlands. At first an authorised antibiotic formulary was
introduced including empiric antibiotic therapy for most
common infectious diseases in children based on local
sensitivity patterns.
Two months later the utilization of antibiotics was analysed.
The method used was described before.18 During an eight-
week period patient charts were reviewed with regard to
antibiotic prescription (generic class, dose, duration and
indication). Simultaneously a questionnaire including 
13 hypothetical clinical cases was sent to all paediatricians and
paediatric residents in the hospital, as described in an earlier
study. 19 Their choice of antibiotic therapy (generic class, dose,
duration) with regard to these cases was evaluated. Both sets
of data were analysed and compared with data found in
earlier studies.18,19 Special attention has been focused on the
presence of uniformity in prescribing behaviour of
paediatricians.
Finally forty-five paediatricians were invited to sit for an
interview. The interview consisted of multiple-choice questions
about efficacy, price, manufacturer, adverse reactions and
development of resistance concerning 11 commonly prescribed
antibiotics. These data were noted and prescribed in detail, for
each above described item the percentage was calculated for
the 11 antibiotics most commonly prescribed in daily practice.
These data were compared with data found in the literature.  
Results
Questionnaire with theoretical cases
Two months after the introduction of an authorised antibiotic
formulary several data concerning uniformity in antibiotic
Chapter five
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prescribing behaviour and actual prescribing behaviour as
evident from the patient charts were collected. First the
assessment of uniformity in prescribing antibiotics showed a
significant shift towards more uniformity in comparison with
an earlier study (table 1). Nineteen paediatricians (46%) and
nine paediatric residents (38%) returned questionnaires, of
which 24 (86%) were completed and four (14%) were returned
without any answers. Greatest variability was found for the
case with suspicion of Gram-negative bacteraemia or arthritis.
Least variability could be shown for the respiratory tract
infections. The dosage of the chosen therapy showed a
considerable variability and did not always agree with the
literature. The dosage of penicillins for central nervous system
infections ranged from 75-200 milligrams/kg versus 13-500
milligrams/kg before the introduction of the antibiotic
formulary. Only 6% of the amoxicillin prescriptions were
within the accepted range in dosage) as described in various
textbooks of paediatrics versus 26% before the introduction
(200-400 milligrams/kg). For a child with suspicion of
respiratory tract infections treated with intravenous or oral
penicillins a dosage of penicillins between 30 and 100
milligrams/kg could be found. More than 95% versus 75%
before the introduction were treated with a dosage as
suggested in formularium or textbooks of paediatrics. The
dosage of aminoglycosides varied between 2 and 8
milligrams/kg, in these cases only netilmycin was chosen. In
80% versus 23% aminoglycosides were dosed in a correct way.
For central nervous system infections more than 85% versus
60% respondents would treat patients with a dosage of
ceftriaxone according to the advised regimen in formularium.
For ceftazidime and cefotaxime more than 95% versus 90%
were treated with correct dosages. Finally the duration of
therapy showed a less remarkable variability than in a study
performed before introduction of the formulary. However,
generally accepted guidelines were breached on several
occasions.
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TABLE 1. Number of chosen antibiotic classes for each case, with in 
parentheses, the number of respondents for the particular case
The first column was before introduction of the formulary, the next columns after
introduction of the formulary. The following antibiotic classes were defined:
penicillins, cephalosporins, aminoglycosides, sulphonamides, vancomycin,
quinolones, metronidazole, and all different combinations of these individual classes.
And the percentages of chosen therapy corresponding with the therapy named in the
introduced formulary.
Case number Paediatricians and residents Same therapy as
and description in formulary
Before After After
(n = 50) (n = 29)
1. a child of three weeks old with bacterial meningitis
15 (45) 4 (24) 71%
2. a four year old girl with a clinically and radiologically proven bacterial 
pneumonia 8 (47) 2 (22) 91%
3. a seven year old boy with sinusitis
5 (44) 2 (22) 86%
4. a five year old girl with  pyelonefritis
12 (43) 3 (22) 86%
5. a four year old child with bilateral otitis media
3 (47) 3 (23) 61%
6. a premature infant, with respiratory distress and sepsis
20 (45) 3 (22) 82%
7. a twelve year old girl with high fever, hypotension, tachycardia
and bloody diarrhoea 18 (36) 5  (16) 17%
8. an eight year old boy with osteomyelitis of the ankle
10 (43) 4  (21) 67%
9. an eight year old girl with atypical pneumonia
6 (43) 1 (23) 65%
10. a three year old girl with bacterial meningitis
12 (47) 2 (22) 86%
11. a four year old girl with endocarditis
17 (30) 2 (12) 92%
12. a two year old girl with infected eczema
8 (41) 3 (18) 33%
13. a nine year old boy with septic arthritis
10 (36) 4 (15) 7%  
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Chart review
During the eight-week period 311 courses of antibiotics were
prescribed for 158 hospitalised patients. Of these 158 patients
99 were boys and 59 were girls. The age of the study
population varied between 0 and 18 years, with a mean of 2.5
years. The median length of hospital stay was 10 days (range
1-164 days) for the children receiving antibiotics. Most
antibiotics were prescribed for children in the neonatal
intensive care unit (35%), followed by 83 patients (52%)
admitted to the nursing departments. Only 13% of all patients
were admitted to the paediatric intensive care unit with one or
more antibiotic courses during their hospitalization. The
average number of antibiotics prescribed was 2.0, comparable
with data found in an earlier study over the years 1994, 1995
and 1996. 18 One single antibiotic course was prescribed in
more than 25% of all cases, two antibiotic courses were
prescribed in 55% of all cases, three antibiotic courses in 10%
of all cases and finally four or even more than four antibiotic
courses were prescribed in about 9% of all courses. There is a
significant difference between the number of courses
prescribed to children on the intensive care unit (2.3) and the
number of courses prescribed to children on the medium care
units (1.8). (P < 0.0001) 
A significant difference could also be found between the route
of administration of antibiotics prescribed for children on the
intensive care unit and children on the medium care. (P <
0.0001) No significant difference in duration of oral and
intravenous prescribed antibiotics could be found. Many
classes of antibiotics were prescribed as shown in Table 2. A
significant difference between the most prescribed antibiotic
classes on the intensive care unit and medium care unit could
be found. Comparing both periods, before and after the
introduction of the antibiotic formulary, the number of
prescribed antibiotics per patient were almost the same. But a
shift in prescribing pattern from broader spectrum towards
small spectrum antibiotics could be shown. For example after
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the introduction of the formulary 42% of all antibiotic
prescriptions in the Intensive Care Unit was made for
penicillins versus 33% before the introduction. For
cephalosporins and vancomycin a decrease in prescriptions in
the Intensive Care Unit could be found. The group of others
consisting of broad spectrum antibiotics like carbapenems or
quinolones were also prescribed in a less percentage after the
introduction of the formulary. Looking at the indication of
prescribed antibiotic therapy, more than 60% of all
prescriptions were started empirically, almost 30% as
prophylaxis and only 10% of all prescriptions for a definite
Chapter five
90
TABLE 2. Generic classes of prescribed antibiotics for children admitted
to the intensive care unit and on the medium care in percentage of total
antibiotic prescriptions on these departments and the corresponding 
p-values between these percentages for the period before the intro-
duction of the formulary and the period after the introduction of the
formulary
Generic classes  Percentage of antibiotic prescriptions 
of prescribed in percentage of all prescriptions
antibiotics Before After
Intensive Medium Intensive Medium
Care unit Care unit Care unit Care unit
(n = 441) (n = 415) (n = 165) (n = 144)
Penicillins 33% 27% 42% 26%
Cephalosporins 16% 16% 8% 18%
Aminoglycosides 31% 11% 37% 17%
Macrolides 2% 7% 2% 3%
Vancomycin 9% 5% 6% 6%
Sulphonamides 1% 20% 1% 18%
Others 8% 14% 4% 12%
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infection. Most commonly, antibiotics were prescribed in case
of suspicion of bacteraemia, followed by the diagnosis of
respiratory tract infections and neonatal or intrauterine
infections. Inter-doctor variability exists for daily-prescribed
doses as well as for the duration of an antibiotic course. Table
3 illustrates the variability in daily-prescribed doses of most
frequently prescribed antibiotics. No difference in mean
duration of prescribed antibiotics could be found between the
intensive care unit and the medium care.
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TABLE 3.  The variation in prescribed dose of mostly prescribed anti-
biotics for several infectious diseases for the period before the intro-
duction of the formulary and the period after the introduction of the
formulary
Antibiotic Before After
range median range median
(mgs/kg/day) (mgs/kg/day)
Penicillins
(central nervous infections) 7.0 - 250 72.5 26.6 - 120 75
Penicillins
(respiratory tract infections)
Oral 10.7 - 111.1 48.0 50 - 100 75
Intravenous 42.9 - 205.1 100.0 47.6 - 400 75
Cephalosporins 19.5 - 200 107.1 32.3 - 150 100
Aminoglycosides
Gentamicin/netilmicin/
tobramycin 0.5 - 12.1 4.9 0.95 - 50.8 4.8
Amikacin 3.6 - 39.5 10.0 not prescribed
Vancomycin 5.0 - 74.3 40.3 17.1 - 76.9 36.1
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Interviews
Finally in the last part of the study 30 paediatricians (67%)
participated. Reasons for refusal were lack of time, or lack of
daily practice in prescribing antibiotics. The gender of the
respondents was fifteen men and fifteen women. The age of
the doctors was between 32 and 57 years, with a mean age of
43 years. The years of experience varied for the general
practice between 7 and 30 years, with a mean of 16 years. For
practice in paediatrics the years of experience varied between 1
and 25 years, with a mean of 10 years. Most existing
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TABLE 4. Familiarity of all 30 paediatricians with 11 most commonly 
prescribed antibiotics in current practice
Range Price Manu- Adverse Resistance 
of facturer reactions
efficacy
Ceftazidime 17 (57%) 12 (40%) 12 (40%) 14 (47%) 11 (37%)
Vancomycin 4 (13%) 15 (50%) 1 (3%) 25 (83%) 10 (33%)
Amoxicillin/
clavulanic acid 19 (63%) 20 (67%) 11 (37%) 29 (97%) 9 (30%)
Trimethoprim 4 (13%) 23 (77%) 6 (20%) 18 (60%) 11 (37%)
Co-trimoxazole 8 (27%) 20 (67%) 7 (23%) 23 (77%) 9 (30%)
Ciprofloxacin 6 (20%) 20 (67%) 2 (7%) 16 (53%) 7 (23%)
Cefuroxime 8 (27%) 23 (77%) 10 (33%) 20 (67%) 13 (43%)
Netilmicin 14 (47%) 7 (23%) 3 (10%) 29 (97%) 12 (40%)
Amoxicillin 13 (43%) 25 (83%) 14 (47%) 29 (97%) 26 (87%)
Imipenem 12 (40%) 15 (50%) 1 (3%) 11 (37%) 5 (17%)
Piperacillin 8 (27%) 11 (37%) 1 (3%) 9 (30%) 5 (17%)
Values are numbers (%) of paediatricians who gave correct answers.
As answers could be correct or incorrect, and all data were complete, 
the complement of values provided are the numbers of paediatricians 
who gave wrong answers.
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subspecialisms in paediatrics were presented between the
respondents. Most physicians prescribed less than 5 courses of
antibiotics each week. A few percentages of the paediatricians
prescribed more than 10 antibiotics a week. The median
number was five antibiotic prescriptions a week.
Study of the familiarity of paediatricians with antibiotics
showed that the knowledge on the expected efficacy of an
individual agent for a particular disease ranged between 13
and 63% depending on the case. As showed in table 4,
questions on most used or prescribed antibiotics (e.g.
ceftazidime) resulted in higher percentages of good answers in
comparison with less used antibiotics (e.g. piperacillin). This
could be found for all aspects of antibiotics that were asked
for. Most physicians could give a reasonable estimate of the
price especially of the most commonly prescribed antibiotics.
More difficult were to answer the questions on the
pharmaceutical manufacturers, which were not known in more
than 80%. Adverse reactions were better known, especially of
the most commonly used or prescribed antibiotics (e.g.
amoxicillin/clavulanic acid, amoxicillin and netilmicin). Only
a few of the paediatricians could give a correct answer about
the resistance pattern of the antibiotics (table 4).
Discussion
Antibiotics are among the most commonly prescribed drugs in
paediatrics. The appropriateness of the treatment decisions of
physicians is a recurrent issue in health care research.10,11
Almost half of all antibiotic prescriptions have been found to
be inappropriate, based on clinical and economical criteria.8 In
addition serious consequences in terms of mortality and
complications can result from inappropriate antibiotic
therapy.9 In general it is recognized that not much is known
about these group of drugs.12 This study tested first the
acquaintance of physicians of most important items of the 
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11 most commonly used or prescribed antimicrobial drugs
nowadays. It could be shown that most paediatricians did not
know much about the range of efficacy, manufacturer, adverse
reactions and the resistance of antimicrobial drugs. The
knowledge of the price of each antibiotic was higher than
expected and as was described in literature.20 No difference
could be found between paediatricians prescribing more or
less antibiotics a week. No significant difference in gender or
years of experience (general or paediatric) could be found for
making the right or wrong diagnosis and for right or wrong
choice of antibiotics. In order to improve the quality of
prescribing antibiotics and health care several solutions are
available.12,21 Continuous education is one possibility,
physicians should be continuously informed about the
antibiotic policy of the hospital, about new antimicrobial drugs
and all developments which are important to know. This study
aimed to get information about the value of the introduction of
an authorised antibiotic formulary in childrenÕs university
hospital. Several professional organisations have tried to
develop strategies to optimise the use of antibiotics in a
hospital. As far as we know until now no study was
performed concerning the implementation of an antibiotic
formulary in a paediatricianÕs population. We analysed two
kinds of variables. At first the presence of uniformity in
empiric antibiotic therapy, followed by the use of antibiotics in
daily practice. A significant shift towards more uniformity in
empiric antibiotic choice could be observed. Almost all cases,
described in the antibiotic formulary were answered with the
correct antibiotic choice. Although the number of responding
doctors was less than the first time a tendency towards more
uniformity could be found for chosen class of antibiotics, as
well as for the chosen dose and duration of the antibiotic
therapy. Another bias of the study is the short time span
between introduction of the formulary and the second
measurement described in the present study.
The use of antibiotics in daily practice showed a total different
Chapter five
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view. Almost the same data were found as established in an
earlier performed study.18 Highest percentage of antibiotic
prescriptions could be observed in the intensive care unit and
for the youngest part of the patient population. Looking at the
generic classes of antibiotics, most prescriptions were made for
penicillins and aminoglycosides. A shift towards use of less
expensive and small spectrum drugs could be demonstrated.
Although we found a significant change in empiric antibiotic
choice in theory and in daily clinical practice a shift towards
less broad spectrum antibiotics could be found. The
introduction of an authorised antibiotic formulary solely is not
enough to change the prescribing behaviour of doctors in a
hospital. It should be accompanied by continuous education,
feedback and monitoring of all variables. 
Only when physicians get sufficient information it is possible
to achieve a better antibiotic policy, resulting in more
appropriate prescribing behaviour, a decrease in antibiotic
costs and possible also a decrease in the emergence of
resistance. 
Changing prescribing behaviour
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CHAPTER SIX
Does the empirical use of 
vancomycin in paediatrics 
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Gram-negative bacteraemia?
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Abstract
Background ¥ Gram-negative bacteraemia in children, a major cause
of morbidity and mortality, may in part be induced by intensive
treatment procedures and unspecific use of antibiotics. Our primary
objective was to study the causal relation between the use of
vancomycin and Gram-negative bacteraemia, for which this
antibiotic is not specifically indicated.
Methods ¥ The study was conducted in a 105-bed tertiary care
childrenÕs hospital in the period of 1994 to 1997. The study pertains
to a cohort of children with suspected bacteraemia, in whom a blood
culture was performed during hospital stay. Using the bacteriological
laboratory registration system we selected all paediatric cases with
bacteriologic proven Gram-negative bacteraemia (n=105), and a
random sample of 225 paediatric controls with negative blood
cultures. Using logistic regression analysis we examined associations
between Gram-negative bacteraemia and the following factors:
preceding use of antibiotics, antacids, corticosteroids, surgery,
mechanical ventilation, parenteral nutrition, invasive
instrumentation, and the intensity of care assessed with the
Therapeutic Intensity Scoring System (TISS 28).
Results ¥ Gram-negative bacteraemia was positively associated with
the use of aminoglycosides, cephalosporins, surgical interventions,
central venous catheters, parenteral nutrition, antacids, and
dexamethasone. The strongest association was with the use of
vancomycin (OR = 8.1, 95% CI: 3.1 to 20.9). In a multiple logistic
regression model containing all above-mentioned variables, the use
of vancomycin remained positively and strongly associated with
Gram-negative bacteraemia (OR = 3.88, 95% CI: 1.34 to 11.21).
Further adjustments and restrictions in the analysis did not
materially change these findings concerning vancomycin.
Conclusions ¥ Among children suspected of bacteraemia there are
several drugs and clinical procedures influencing the risk for 
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Gram-negative bacteraemia. Empiric use of vancomycin is strongly
and independently associated with Gram-negative bacteraemia. The
safety of using vancomycin solely on the basis of suspicion of
bacteraemia in children may not be warranted.
Chapter six
102
Binnenwerk Van Houten def  14-03-2001  11:54  Pagina 102
Introduction 
Gram-negative organisms are common causes of bacteraemia.
In children these organisms are responsible for more than 50%
of all cases of bacteraemia and cause a significant morbidity
and mortality.1, 2 The extensive use of antibiotics in outpatient
settings, increased use of neonatal and paediatric intensive
care units and the prolonged use of central intravenous
catheters, chemotherapy and corticosteroids make Gram-
negative bacteraemia a significant problem in tertiary care
paediatric hospitals.1 In Gram-negative bacteraemia in
childhood most frequently the enteric bacteria Escherichia coli,
Enterobacter, Klebsiella and nonenteric bacteria, such as
Pseudomonas are isolated.1
It is generally accepted that antecedent antibiotic exposure
predisposes the individual patient to colonisation and infection
with resistant microorganisms.3,4 The widespread use of 
broad-spectrum antibiotics and inappropriate empiric
antibiotic treatment result in increased mortality and the
emergence of increasingly resistant microorganisms.5,6 Early
recognition and correct treatment of Gram-negative
bacteraemia are of paramount importance to prevent morbidity
and mortality.1 The use of antibiotics and the intensity of care
are possibly important risk factors for patients to develop
Gram-negative bacteraemia. On the other hand intensive
antibiotic use and other intensive treatments and procedures
are also a reflection of disease severity; extensive antibiotic
medication and invasive procedures are more frequently
applied in the more severely ill children, particularly those
with Gram-negative bacteraemia. 
A challenge is therefore to discern between intensive use of
antibiotics and means of care as actual predictors of Gram-
negative bacteraemia or as consequences of serious disease
from Gram-negative bacteraemia. Our primary objective was
to quantify the risk of Gram-negative bacteraemia associated
Does the empirical use of vancomycin increase the risk
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with the empiric use of antibiotics and with indicators for
intensity of care. 
Methods
Patients
The study was performed at the Beatrix ChildrenÕs Hospital, a
paediatric university hospital in the northern part of the
Netherlands. The hospital is the only tertiary referral center for
a population of approximately 2.5 million. The study pertains
to a cohort of children treated between 1994 and 1998 (from
Jan.1, 1994 through Dec.31, 1997) in whom a blood culture was
performed during hospital admission because of suspected
bacteraemia. Using the record system of the Department of
Microbiology and Epidemiology we selected from this period
all 108 recorded positive blood cultures with Gram-negative
microorganisms, and a random sample of 229 registered
negative blood cultures. The concomitant resistance patterns of
isolated micro-organisms were available for analysis. Seven
patients were admitted twice. As we intended to study
patients and not episodes we excluded each second admission
thereby leaving 105 paediatric patients with proven Gram-
negative bacteraemia (cases) and 225 patients with proven
negative blood cultures (controls) for analysis. There were
three sets of twins in the control group who were each
included in all analyses.
Measurements
We retrieved information about risk indicators from the
medical files pertaining to a period of maximally 10 days
before the venipuncture for bloodculture was taken. We
categorized the use of antibiotics by the following categories:
penicillins, aminoglycosides, cephalosporins, vancomycin, and
Chapter six
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other antibiotics. Additionally, we recorded the use of
corticosteroids, selective bowel decontamination, and antacids.
Furthermore, we recorded patient characteristics (age, gender,
body weight), the number of attended hospitalization units
during admission, the department attended at the time of risk
indicator determination, the attending subspecialties, duration
of hospitalization, surgical intervention, use of invasive
instrumentation and type of intervention. The intensity of care
was estimated by using the Therapeutic Intensity Scoring
System TISS-28.7,8
Data analysis
Logistic regression analysis was used to assess odds ratioÕs for
the univariate associations between the abovementioned
measurements and the outcome, Gram-negative bacteraemia
versus no bacteraemia. Data were entered into SPSS 9.0
release, 1998. Subsequently, multiple logistic regression was
used to assess the extent to which associations found between
antibiotics use and the outcome were independent of other risk
indicators.9
Results
Table 1 shows general characteristics of cases and controls and
clinical follow-up data. Compared with controls, cases were on
average somewhat younger and had been more ill as indicated
by a statistically significantly longer duration of
hospitalization, higher TISS-score and higher mortality. The
frequencies of Gram-negative bacteraemia were clearly
dependent on diagnoses.
Table 2 shows univariate associations between various
exposures and Gram-negative bacteraemia. The use of
antibiotics such as aminoglycosides, cephalosporins,
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vancomycin, other antibiotics, and other drugs such as
antacids and dexamethasone were each risk indicators for
Gram-negative bacteraemia. The same applied to invasive
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106
TABLE 1. Baseline characteristics and clinical follow-up
No bacteraemia Gram-negative
bacteraemia
Number of patients 225 105
Age (years) 0.3 [0 Ð 18.3] 0.3 [0 Ð 16.2]
Male/female 1.03 1.7
Body weight (kg) 5.3 [0.7 Ð 99.0] 4.9 [0.6 - 69.5]
TISS-score* 13 [1 - 42] 19 [4 Ð 42]**
Clinical follow-up:
Duration of admission (days) 12 [range 0 - 370] 27 [range 0 - 217]**    
Primary diagnosis in:
Infectiology 28 15
Hematology/oncology 26 15
Gastro-enterology 29 20
Neonatology 59 39
Nephrology 5
Cardiology 21 3
Pulmonology 33 1
Congenital pathology 9 1
Neurology 19 2
Unspecified 1 4
Died 19 34***
Values are median [range], unless indicated otherwise.
* TISS-28: Therapeutic Intensity Scoring System, based 
on 28 items measuring the intensity of treatment.
** p < 0.0001 (Mann Whitney U test).
*** p < 0.0001 (Chi-square = 30.4 , df = 1).
Binnenwerk Van Houten def  14-03-2001  11:54  Pagina 106
Does the empirical use of vancomycin increase the risk
107
TABLE 2. Results of univariate logistic regression with an indicator for
presence of Gram-negative bacteraemia or no bacteraemia as dependent
variable
Variable* OR 95% CI
Continuous independent variables
Age (months) 1.00 0.99 to 1.00
Body weight (kg) 0.99 0.97 to 1.01
TISS-28 1.06 1.03 to 1.09
Dichotomous independent variables
Gender (male/female) 0.61 0.38 to 0.98
Use of antibiotics (yes/no) 2.16             1.34 to 3.46
Use of penicillins (yes/no) 1.59             0.94 to 2.69
Use of aminoglycosides (yes/no) 2.17 1.21 to 3.87
Use of cephalosporins (yes/no) 2.26 1.15 to 4.45
Use  of vancomycin (yes/no) 8.06 3.12 to 20.87
Use of other antibiotics (yes/no) 3.82 1.96 to 7.46
Use of SDD** (yes/no) 4.42 0.80 to 24.50
Use of dexamethasone (yes/no) 3.19 1.73 to 5.88
Use of antacids (yes/no) 3.51 1.98 to 6.23
Surgical intervention (yes/no) 1.88 1.05 to 3.38
Abdominal surgery (yes/no) 2.52 1.19 to 5.31
Central venous catheter (yes/no) 2.24 1.40 to 3.60
Drain (yes/no) 0.63 0.29 to 1.39
Thoracal drain (yes/no) 1.77 0.68 to 4.63
Tracheostoma (yes/no) 0.01 Undefined
Urinary catheters (yes/no) 0.60 0.12 to 2.96
Mechanical ventilation (yes/no) 1.42 0.89 to 2.26
Parenteral nutrition (yes/no) 2.27 1.36 to 3.80
* The variables were measured up to 10 days before the blood culture was taken.
For all dichotomous variables non-users were the reference category
and for gender, females were the reference category.
** SDD is Selective Gastrointestinal Decontamination.
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procedures such as surgical interventions, use of a central
venous catheter and parenteral nutrition. These findings were
also reflected in the association found with the TISS 28 score. 
The strongest univariate association, OR = 8.06, 95% CI: 3.12 to
20.87, was with empiric use of vancomycin. Vancomycin is
specifically not indicated for Gram-negative bacteraemia,
except Flavobacterium infection. We therefore further analysed
the association between vancomycin and Gram-negative
bacteraemia. First, we assessed the extent to which this
association was dependent on other possibly confounding
factors associated with Gram-negative bacteraemia. Second,
we evaluated whether this association was due to the
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TABLE 3. Results of bivariate logistic regression providing the risk 
for Gram-negative bacteraemia with the use of vancomycin 
combined with each of the given variables as independent variables
Use of vancomycin combined with OR 95% CI
Gender (male/female) 8.50 3.25 to 22.24
Use of antibiotics (yes/no) 6.16 2.26 to 16.77
Use of aminoglycosides (yes/no) 7.36 2.82 to 19.21
Use of cephalosporins (yes/no) 7.09 2.64 to 19.03
Use of other antibiotics (yes/no) 5.94 2.22 to 15.90
Use of dexamethasone (yes/no) 7.29 2.77 to 19.17
Use of antacids (yes/no) 6.09 2.29 to 16.23
Surgical intervention (yes/no) 7.37 2.82 to 19.26
Abdominal surgery (yes/no) 7.42 2.84 to 19.37
Central venous catheter (yes/no) 7.16 2.73 to 18.96
Parenteral nutrition (yes/no) 7.81 2.98 to 20.44
TISS-28 8.14 3.10 to 21.38
The variables were measured up to 10 days before 
the blood culture was taken.
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combined prescription of antibiotics and whether it persisted
within subgroups.
In separate bivariate logistic regression analyses we studied
the extent to which the association between Gram-negative
bacteraemia and use of vancomycin depended on each of the
other factors that were statistically significantly associated in
the univariate analyses. Table 3 shows that in a bivariate
logistic model, none of the other variables had a major
influence on the association between vancomycin use and the
occurrence of Gram-negative bacteraemia. This association
remained positive and statistically significant with each of the
adjustments. The odds ratio for use of vancomycin then
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TABLE 4. Multivariate logistic regression showing relative risk of
vancomycin use and Gram-negative bacteraemia with various
adjustments
Model Vancomycin given with OR 95% CI
Model 1 Aminoglycosides, cephalosporins,
other antibiotics, dexamethasone,
antacids 3.97 1.39 to 11.31
Model 2 Surgical intervention, central venous
catheter, parenteral nutrition 6.70 2.53 to 17.75
Model 3 Aminoglycosides, cephalosporins,
other antibiotics, dexamethasone,
antacids, surgical intervention,
central venous catheter, parenteral
nutrition 3.88 1.34 to 11.21
Values are Odds Ratios (OR) with 95% Confidence Intervals (CI) indicating the relative risk of
vancomycin use for gram-negative bacteraemia, allowing for the effects of the other variables
provided in the respective models.
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ranged from OR = 5.94, 95% CI: 2.22 Ð 15.90, when adjusted for
use of other antibiotics, to OR = 8.14, 95% CI: 3.10 Ð 21.38,
when adjusted for the mean TISS 28 score, while all other odds
ratios in between that range were statistically significant (data
not shown).
In subsequent multivariate logistic regression models all
variables concerning drug use and invasive procedures that
showed statistically significant univariate associations were
simultaneously included. The results are shown in table 4. A
first model with vancomycin adjusted for other drug use,
including other antibiotics, yielded a somewhat lower odds
ratio for vancomycin. It decreased less in a second model with
vancomycin adjusted for invasive procedures. The odds ratio
of vancomycin again decreased when a full multivariate model
was used, (OR = 3.88, 95% CI: 1.34 to 11.21). Thus, adjustment
for other drug use lowered the association more than
adjustment for invasive procedures. 
We further assessed whether the effect of vancomycin differed
within users of other antibiotics (table 5), indicating among, for
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TABLE 5. Results of univariate logistic regression with an indicator for
the presence of Gram-negative bacteraemia as dependent variable and
vancomycin use as independent variable, restricted to users of other
antibiotics
Restricted to users of OR 95% CI OR* 95% CI*
Antibiotics (n = 131) 6.16 2.26 to 16.77 5.65 2.01 to 15.94
Penicillins (n = 78) 5.10 1.23 to 21.09 5.68 1.24 to 25.95
Aminoglycosides (n = 58) 2.67 0.60 to 11.91 4.16 0.76 to 22.65
Cephalosporins (n = 39) 5.10 1.11 to 23.37 3.59 0.65 to 19.76
Other antibiotics (n = 42) 2.63 0.59 to 11.65 2.40 0.60 to 19.15
* Adjusted for indicators of surgical intervention, central venous catheter, parenteral nutrition.
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instance, users of penicillin (n=78) the risk of Gram-negative
bacteraemia in users of vancomycin as compared with non-
users of vancomycin. When restricted to users of antibiotics in
general (n=131), vancomycin still showed an OR = 6.16, 95%
CI: 2.27 to 16.75. Similar results were found when analysis was
restricted to use of penicillins and cephalosporins. When
restricted to use of aminoglycosides or the category called
other antibiotics the odds ratios decreased somewhat. The
effect of vancomycin also persisted within the domain of users
of dexamethasone and antacids (data not shown). Further
adjustment for invasive procedures did not materially affect
these associations.
Subsequently, we looked at the effect of vancomycin used in
combination with each of the other antibiotics on Gram-
negative bacteraemia, with non-users of such combinations as
the respective reference groups. Vancomycin combined with
penicillin showed an OR = 6.03, 95% CI: 1.57 to 23.19; with
aminoglycosides: OR = 4.43, 95% CI: 1.09 to 18.07; with
cephalosporins: OR = 6.85, 95% CI: 1.82 to 25.84; and with
other antibiotics: OR = 6.85, 95% CI: 1.82 to 25.84. Table 6
shows that the effects of vancomycin combined with the other
antibiotics did not differ much from the univariate effect of
vancomycin on Gram-negative bacteraemia. In contrast, when
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TABLE 6.  Effect of vancomycin used in combination with other
antibiotics on Gram-negative bacteraemia, with non-users of such
combinations as reference groups
Vancomycin in combination with OR 95% CI
Penicillin 6.03 1.57 to 23.19
Aminoglycosides 4.43 1.09 to 18.07
Cephalosporins 6.85 1.82 to 25.84
Other antibiotics 6.85 1.82 to 25.84
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we restricted the data to users of vancomycin only (table 7),
there was no effect observed of other antibiotics on the
occurrence of Gram-negative bacteraemia, while in non-
vancomycin users the effects were similar to those in the
Chapter six
112
TABLE 7. Results of univariate logistic regression with an indicator for
presence of Gram-negative bacteraemia as dependent variable and use of
various antibiotics as independent variables, by use of vancomycin and
by use of a central venous catheter
Variable Vancomycin
Yes (n=25) No (n=305)
OR 95% CI OR 95% CI
Vancomycin
Penicillins 0.73 0.12 to 4.59 1.45 0.81 to 2.60 
Aminoglycosides 0.46 0.07 to 2.99 2.20 1.17 to 4.15
Cephalosporins 0.90 0.14 to 5.65 1.56 0.69 to 3.57
Other antibiotics 0.90 0.14 to 5.65 3.35 1.55 to 7.21
Variable Central venous catheter
Yes (n=150) No (n=180)
OR 95% CI OR 95% CI
Vancomycin 5.57 1.72 to 18.04 10.95 2.12 to 56.49
Penicillins 1.27 0.62 to 2.58 1.70 0.75 to 3.86
Aminoglycosides 1.31 0.63 to 2.72 3.36 1.27 to 8.93
Cephalosporins 2.92 1.14 to 7.46 1.37 0.45 to 4.14
Other antibiotics 4.09 1.65 to 10.16 2.77 0.96 to 7.94 
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overall analysis (see table 2). One indication for use of
vancomycin is when a central venous catheter is suspected to
be infected. Table 7 also shows the associations between
vancomycin and other antibiotics and Gram-negative
bacteraemia separately in those who had had a central venous
catheter and in those who had not. The overall effect of
vancomycin was modified by the presence of a central venous
catheter. Of patients who did not have central venous catheters
but had Gram-negative bacteraemia (n=44), 38 (82,6%) were
immune-compromised in the broadest sense, 3 had a
cardiopulmonary diagnosis and 3 had other diagnoses.The
overall effect of vancomycin on Gram-negative bacteraemia
clearly persisted when restricted to children who had had this
indication for vancomycin, but was even stronger among those
who had not.
The positive association between vancomycin and Gram-
negative bacteraemia might be related to specific routine
procedures within wards or with disease severity. Table 8
shows that within paediatric and neonatal intensive care units
the associations remained strongly positive, although
confidence intervals were wide. In general wards a positive
association remained that was close to the univariate effect.
Restriction of analyses to those who had ultimately died and
those who had not, again yielded associations that were very
similar to the univariate effect of vancomycin. None of the
other antibiotics was clearly associated with Gram-negative
bacteraemia among those who died (data not shown). We
further looked at whether specific diagnoses could explain the
association between vancomycin use and Gram-negative
bacteraemia. When diagnosis was entered as a confounder in
the model, we found OR = 13.88, 95% CI: 4.36 to 44.13 for
vancomycin use. Gram-negative bacteraemia was more
common with some diagnoses than others. Compared with
cardiologic, pulmonic, neurologic diagnoses and congenital
malformations, diagnoses in the fields of infectiology,
hematology/oncology, gastro-enterology, neonatology and
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nephrology had a much higher chance of Gram-negative
bacteraemia (OR = 6.71, 95% CI: 3.10 to 14.52) (table 1). When
we used an arbitrary cut of point of diagnoses with more than
or lower than 50% Gram-negative bacteraemia, the effects of
vancomycin were in the same positive direction and possibly
stronger among diagnoses with lower prevalence of Gram-
negative bacteraemia (table 8). Similar findings were obtained
when diagnoses were grouped as immunocompromised,
cardiopulmonary and other (data not shown).
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TABLE 8. Results of univariate logistic regression with an indicator for
presence of Gram-negative bacteraemia as dependent variable and use of
vancomycin as independent variable, by ward, vital status, and diagnosis
Variable N OR 95% CI
Ward
Intensive care 61 13.05 1.46 to 116.98
Neonatal intensive care 131 14.10 1.64 to 121.20
General wards 138 5.20 1.43 to 18.91
Vital status
Dead 53 6.48 0.75 to 55.80
Alive 277 6.59 2.17 to 20.02
Relative frequency of 
Gram-negative bacteraemia
> 50% 235 8.91 2.50 to 31.73
(diagnoses infection, hematology/oncology,
gastro-enterology, neonatology, nephrology)
< 50% 90 26.33 4.34 to 159.74
(diagnoses cardiology, pulmonology, 
congenital disease, neurology)
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Discussion
In our study on clinical risk indicators for Gram-negative
bacteraemia we found positive associations between use of
antibiotics, other drugs and indicators of intensity of care. Our
study shows an strong positive and independent association
between the empirical use of vancomycin and the existence of
Gram-negative bacteraemia.
Before further interpreting our data, some methodological
issues concerning our study need to be addressed. Using
bacteriologic registry data we obtained solid outcome data in
which it is very unlikely that misclassification has occurred.
The original intent of this study was to identify risk indicators
for Gram-negative bacteraemia from which an easily usable
clinical risk score could be constructed. This to some extent
directed the way in which exposure data were collected.
Assessment of risk indicators was performed in retrospect. As
exposure assessment from medical files could not be blinded
for the bacteriologic outcome we chose to use those categories
(yes/no) that were least vulnerable to interpretation. There
was much variation in patient characteristics and medical
backgrounds, but the most important factors were collected.
Given the original goals of the study data collected about
antibiotics were confined to their use or not. We did not gather
data on Gram-positive bacteraemia, as we consider negative
blood cultures the optimal reference group given our research
question. We used, only those risk indicators that were noted
in patientsÕ charts prior to the physicianÕs knowledge of the
results of blood cultures. With respect to antibiotics this means
that the present results pertain only to their empiric use.
In our analyses, we attempted to assess, whether the
association between vancomycin use and Gram-negative
bacteraemia was genuine or biased.10 Use of vancomycin
showed the highest positive association with Gram-negative
bacteraemia and it was the only antibiotic that remained
positively associated with Gram-negative bacteraemia in a
Does the empirical use of vancomycin increase the risk
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multivariate analysis. The univariate positive associations
between the other antibiotics and Gram-negative bacteraemia
might be explained by the fact that they were prescribed for
suspected Gram-negative bacteraemia. The finding with
vancomycin, however, is surprising because vancomycin is not
indicated for Gram-negative bacteraemia.11 One explanation
might be that vancomycin is empirically used in combination
with other antibiotics as broad antibiotic coverage for
suspected bacteraemia. A positive association for vancomycin
might then just be the result of being combined with another
antibiotic used because of suspicion of Gram-negative
bacteraemia. However, this effect persisted when we analysed
in only those who used other antibiotics. Overall, taken into
account that some of these restrictions yielded small numbers
of patients, there was a consistent tendency for positive
associations between vancomycin and Gram-negative
bacteraemia within users of other antibiotics. Similarly,
vancomycin combined with each of the other antibiotics
showed clear positive associations, while among those using
vancomycin other antibiotics were not associated with Gram-
negative bacteraemia. Although the analysis was based on
small numbers of patients, this may indicate that the positive
associations found with antibiotic combinations including
vancomycin were largely due to the exclusive effect of
vancomycin.
Another explanation might be that vancomycin was used for
specific indications such as a central venous catheter. If
vancomycin is (routinely) used as empiric antibiotic coverage
with central venous catheters, one might find a spurious
association between vancomycin and Gram-negative
bacteraemia. This would in fact only be due to severe
infectious disease, predominantly caused by Gram-negative
bacteria, inducing the use of central venous catheters, in turn
inducing the use of vancomycin. However, the association
between vancomycin use and Gram-negative bacteraemia was
even stronger when restricted to children without central
Chapter six
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venous catheters than in children with central venous
catheters. This is an argument against such a spurious
association. 
The patients in our study had rather different backgrounds.
One might argue that the association between vancomycin and
Gram-negative bacteraemia has to do with that heterogeneity.
It is conceivable that this association is induced by specific
routinely performed prescriptions or procedures among
specific groups of children. However, our analysis indicated
that the association held within specific wards and within
categories indicating severeness of disease (e.g., those who
died and those who did not). Although Gram-negative
bacteraemia was more frequent with some diagnoses than
others, our results do not indicate that diagnosis was a
confounder. The association seemed even stronger with
diagnoses in which Gram-negative bacteraemia is least
frequent (table 7).
Another possible confounding factor could be exposure time
defined as the time between admission and infection. Longer
exposure time might be associated with an increased risk of
getting vancomycin prescribed as well as with more severe
disease such as Gram-negative bacteraemia. However, there
was no relation between exposure time and Gram-negative
bacteraemia. A model with vancomycin and exposure time as
independent variables did not alter the odds ratio for
vancomycin as compared with the univariate model with
vancomycin.
The existence of an association between empiric use of
vancomycin and the occurrence of Gram-negative bacteraemia
has been the subject of previous studies, although data are
very scarce and we have not found data in the literature that
would provide a definite answer in either direction.
Antecedent administration of antibiotics and number of ICU
admissions are associated with colonization by Gram-negative
bacilli.12 Ideally, in order to find a causal relation between use
of vancomycin and Gram-negative bacteraemia, one would use
Does the empirical use of vancomycin increase the risk
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a design in which empiric use of vancomycin would be
random allocated to children suspected of bacteraemia. In a
retrospective study on the effects of empirical use of
vancomycin paste in oncology patients such an association was
found to be absent.13 However, in one trial in febrile
neutropenic children with cancer a randomized comparison of
vancomycin versus amikacin was made, in which vancomycin
use was associated, although not statistically significant, with
increased frequency of secondary Gram-negative
bacteraemia.14 Another trial in 747 febrile granulocytopenic
adult patients with cancer in which vancomycin was added to
empiric combination antibiotic therapy no significant
difference occurred between these groups.15 There has to our
knowledge been no later reporting of such an adverse effect of
vancomycin, one reason perhaps being that most randomised
studies with vancomycin did not pertain to its empiric use.16-18
Our study is in agreement with the finding of Viscoli et al.14
We feel that the association between empiric vancomycin use
and Gram-negative bacteraemia may well be genuine and
causal as it is quite strong and consistent and insensitive to
various adjustments and restrictions in the dataanalysis. While
emerging resistance against vancomycin is a very important
problem in itself,19-22 our data additionally indicate Gram-
negative bacteraemia to be an important adverse consequence
of its empiric use. Our results should be confirmed in larger
randomized prospective studies. Meanwhile, one could justify
particular caution in of empirical use of vancomycin. 
Chapter six
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General discussion
Since their discovery antibiotics have considerably changed the
epidemiology and prognosis of bacterial infectious diseases.
Complications of frequent bacterial infections such as otitis
media have become uncommon and the mortality and
morbidity of severe infections as meningitis and osteomyelitis
have been reduced dramatically. Antibiotics were considered
miracle drugs during the second half of this century and the
number of new agents that has been developed in the decades
following the discovery of penicillin is striking. 
Antibiotics are among the most frequently prescribed drugs, in
adults as well as in children.1 Soon after their introduction in
clinical practice, it was recognised that antibiotics were
overused and misused.2 Studies in hospitals show that in more
than half of the cases for which antibiotics are prescribed there
was no need for the prescription, an inappropriate agent was
chosen or the dose was incorrect.3 Antibiotics account for up to
50% of the pharmacy budget in some hospitals. The rising
costs of health care together with the governmental urgency in
most countries to reduce or control these costs make it
necessary to rationalise antimicrobial related expenditure.
Therefore it is necessary to increase our knowledge concerning
the actual use of antibiotics, the associated costs and the
prescribing behaviour of doctors.
Until now limited information is available on the use of
antibiotics in children. Only a small number of studies have
reported on the use of antibiotics in paediatrics. The most
commonly used parameter for use of antibiotics in adults, the
Daily Defined Doses, has been described only once for a
paediatric population.4 A combination of other more indirect
variables is used more often.5-12 Not much attention has been
paid to the costs of antibiotics in relation to prescribing
patterns.13 The studies mentioned in this thesis are focused on
these aspects of the use of antibiotics in paediatrics. 
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We presented the first study of antibiotic expenditure in a
childrenÕs hospital. It shows that a rough analysis of costs of
antibiotics results is an incomplete view of the real antibiotic
expenditure. The reason is that in the interpretation of these
costs are not included detailed specifications of costs of
antibiotics related to generic class, changes in retail price,
changes in patient characteristics, or changes in hospital
policies regarding formularies. Increasing costs in health care
could be linked to the use of more expensive antibiotics.
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FIGURE 1. Antibiotic expenditure in Beatrix ChildrenÕs Hospital
(1984 - 1998).
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Disclosure on itself of antibiotic-related expenditures resulted
in a decrease in antibiotic expenditure over the years of the
study (figure 1). Directing the attention of doctors towards
their prescription attitudes, even without directly requiring a
change in attitude during our study probably caused this
beneficial effect.
Next to analysis of the antibiotic costs a detailed description of
the actual use of antibiotics in daily practice in paediatrics was
carried out. Results as percentage of antibiotic use, division of
antibiotic prescription as described in the literature were
confirmed by our data. Mostly antibiotics were prescribed on
an empirical basis, without convincing evidence to confirm the
diagnosis of a bacterial infection. It is possible that in a number
of cases antibiotics would have been discontinued earlier or
would not have been given at all if more accurate diagnostic
procedures had been available to prove a bacterial infection.
However, sometimes it is legitimate to start empirical
antibiotic therapy in unproven but suspected bacterial diseases
in childhood, e.g. in febrile infants less than 3 months old, or
children with meningitis and a negative Gram-stain of the
cerebrospinal fluid.
As suspected we found a lack of uniformity in prescribing
antibiotics by several groups of paediatricians. After the
introduction of an authorised formulary, in which the empiric
treatment of the most common infectious diseases in
paediatrics are described, a significant increase of uniformity
in prescribing behaviour was found as well as a more
corresponding therapy with the formulary (table 1). However,
a strictly enforced formulary is only one possible successful
strategy. Other strategies to improve the prescribing patterns
of antibiotics probably resulting in significant savings and in a
significant impact on a physicianÕs prescribing patterns are for
example the use of a separate antibiotic order form,
implementation of strict guidelines according to diagnostic
algorithms, or computer-assisted antimicrobial therapy. Next
to this continuing education in antibiotics and its consequences
General discussion
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TABLE 1. Number of chosen antibiotic classes for each case, with in 
parentheses, the number of respondents for the particular case
The first column was before introduction of the formulary, the next columns after
introduction of the formulary. The following antibiotic classes were defined:
penicillins, cephalosporins, aminoglycosides, sulphonamides, vancomycin,
quinolones, metronidazole, and all different combinations of these individual classes.
And the percentages of chosen therapy corresponding with the therapy named in the
introduced formulary.
Case number Paediatricians and residents Same therapy as
and description in formulary
Before After After
(n = 50) (n = 29)
1. a child of three weeks old with bacterial meningitis
15 (45) 4 (24) 71%
2. a four year old girl with a clinically and radiologically proven bacterial 
pneumonia 8 (47) 2 (22) 91%
3. a seven year old boy with sinusitis
5 (44) 2 (22) 86%
4. a five year old girl with  pyelonefritis
12 (43) 3 (22) 86%
5. a four year old child with bilateral otitis media
3 (47) 3 (23) 61%
6. a premature infant, with respiratory distress and sepsis
20 (45) 3 (22) 82%
7. a twelve year old girl with high fever, hypotension, tachycardia
and bloody diarrhoea 18 (36) 5  (16) 17%
8. an eight year old boy with osteomyelitis of the ankle
10 (43) 4  (21) 67%
9. an eight year old girl with atypical pneumonia
6 (43) 1 (23) 65%
10. a three year old girl with bacterial meningitis
12 (47) 2 (22) 86%
11. a four year old girl with endocarditis
17 (30) 2 (12) 92%
12. a two year old girl with infected eczema
8 (41) 3 (18) 33%
13. a nine year old boy with septic arthritis
10 (36) 4 (15) 7%  
Binnenwerk Van Houten def  14-03-2001  11:54  Pagina 124
is of great importance.14-17 Further research on the success of
different programs in optimising antibiotic therapy, while
safeguarding patient outcome, and curtailing the antibiotic
budget is warranted.
Another very important problem related at least partially to
inappropriate prescription of antibiotics is the emergence of
resistance. Antibiotics not only exert a therapeutic effect but
also alter the ecology of the microflora of the body and the
environment.18 The development of resistant micro-organisms
was recognised by Paul Ehrlich as a potential problem during
his early studies of organic arsenicals almost 100 years ago.2
Multiple-drug-resistant micro-organisms derived through the
transfer among species of plasmids or transduction by
bacteriophages are an amplification of this problem. A causal
relationship between antibiotic usage and development of
resistance of micro-organisms in hospitals has been suggested
on the basis of consistent associations of the emergence of
resistant strains with concurrent variations in antibiotic use in
populations over time.19 Several groups have presented
evidence that control of antibiotic use can result in reversal of
the bacterial population to sensitive micro-organisms.20-22
However Toltzis indicated that antibiotic restriction policies in
an ICU failed to diminish the size of the endemic reservoir of
antibiotic-resistant Gram-negative rods, and suggested that
such policies in the absence of broader efforts to limit
antibiotic use will have little impact.23 Other important issues
like the widespread use of antibiotics in the community and
veterinary exposure of antibiotics in livestock will need to be
addressed simultaneously.
Although the initial aim of this study was to decrease the rate
of emergence of resistance it was impossible to measure this in
the available time-frame. Moreover, a lack of uniformity in
defining resistance, variations in susceptibility test methods
(and interpretation of the results), potential study selection
biases, and variations in infection control measures in the
hospital were confounding variables.24
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As we all know and described before an important and
causing relationship exists between antibiotic use and
antibiotic resistance. Therefore we performed a study to
discover risk factors in the development of Gram-negative
bacteraemia, on of the life threatening symptoms in
paediatrics. This study shows an unexpectedly strong positive
and independent association between the empirical use of
vancomycin and the existence of Gram-negative bacteraemia.
(Chapter 6) This is surprising because vancomycin is not
indicated for Gram-negative bacteraemia. Selective antibiotic
pressure against Gram-positive micro-organisms could cause a
shift in colonisation resistance favouring the multiplication
and translocation of Gram-negative micro-organisms. This
study demonstrated unexpected epidemiological phenomena
connected with the use of broad-spectrum antibiotic therapy in
the hospital.
In conclusion antibiotics are responsible for a high percentage
of the health care costs.3 About 35% of all hospitalised patients
receive one or even more courses of antibiotics during their
admission. This could be shown for adults as well as for the
paediatric population.5-7,25-28 Until now only a few studies have
been performed concerning use of antibiotics in a paediatric
population. To our knowledge this thesis is the first collection
of studies concerning most aspects of the use of antibiotics and
prescribing behaviour in paediatrics. As shown in this study
saving money by using less expensive drugs, a higher
uniformity in prescribing behaviour, a more rational use of
antibiotics and getting people aware of the emergence of
resistance could be the result. Most important and most
difficult is to get doctors aware of the consequences of
antibiotic use and misuse.3,29,30 In order to improve antibiotic
prescribing a more strict and more uniform policy is
warranted. This policy should be based on local sensitivity
patterns and should be revised regularly. Some recently
performed studies showed an association between the prior
use of antibiotics and the development of resistance.31-34
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Because of these emergent threats it is necessary to be
informed continuously about the use of antibiotics in the
hospital. This monitoring of antibiotic use should be associated
with continuous feedback and education of each prescribing
doctor. Infectious disease specialists, medical microbiologists,
pharmacists or ideally a combination of these professionals
should be made responsible for these tasks. A decrease in
health care costs and especially a diminishing of antibiotic
expenditure will only be attained by continuous monitoring
antibiotic usage, and antibiotic-related costs, and increasing
awareness of prescribers of these results. Several intervention
strategies could be used to change the prescribing behaviour of
doctors.35,36 According to the literature effective change
strategies were reminders, patient-mediated interventions,
outreach visits, sessions with opinion leaders, and multifaceted
activities. Audit with feedback and educational materials were
less effective and formal Continuous Medication Education
conferences or activities, without enabling or practice-
reinforcing strategies, had relatively little impact.36 Studies
with these different methods should be performed to come to
the best solution for changing prescribing behaviour of doctors
and streamlining antibiotic therapy. It would be wise and
more effective to make plans on a regional, national or even
international level. For the future the most important problem
is the emergence of resistance. Antimicrobial resistance results
in increased morbidity, mortality, and costs of health care.
Several societies have described guidelines or statements for
the prevention of antimicrobial resistance.37-39 Again
appropriate antimicrobial stewardship that includes optimal
selection, dose, and duration of treatment, as well as control of
antibiotic use will be of paramount importance.37 A
multidisciplinary, system-oriented approach, catalysed by
hospital leadership or even by governmental leadership, is
required to address this urgent problem.38 For example in the
Netherlands an Antibiotic Policy Foundation called Stichting
Werkgroep Antibiotica Beleid (SWAB) is founded to optimize
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antibiotic therapy in the Netherlands.40 One of the SWAB
projects is the development of national guidelines for the use
of antibiotics in hospitals.40-43 These guidelines are prepared by
a committee of experts and reviewed by external consultants:
infectious disease specialists, medical microbiologists and
pharmacists. The SWAB hopes that these guidelines will make
the prevention of antibiotic resistance a major factor in the
choice of the antibiotic. Streamlining antibiotic therapy is an
important tool in this respect. These are important challenges
at the beginning of the 21st century. In this century more
research should be performed in antibiotic use and its possible
consequences for all medical specialties using or prescribing
antibiotics during a continuous period. 
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Summary of the studies
Since the introduction of penicillins in 1941 these drugs had
been used increasingly over the ensuing years. In paediatrics
antibiotics are of the most frequently prescribed drugs and
widespread misuse has been described. Nowadays we are
dealing with large problems of rising expenditures and the
emergence of antibiotic resistance. Several professional
organizations promote a more prudent overall use of
antibiotics. One of the responsible factors is the prescribing by
doctors. 
We wanted to know how doctors are prescribing antibiotics in
our paediatric hospital. A higher uniformity in antibiotic
prescribing could result in a decrease in antibiotic
expenditures and after all could possible block the further
development of resistance. 
Therefore we started in 1995 a research project concerning
antibiotic use in paediatrics. Several methods are available to
get the necessary information. 
Chapter one contains a concise review of the literature
including definitions of the major problems of the use of
antibiotics in paediatrics. After a detailed description of the
use, overuse and abuse of antibiotics more emphasis was put
on the relation between prescribing and development of
resistance. Finally some possible strategies for the future were
disclosed. We focused on the necessity to implement these
strategies very soon in order to have a reasonable chance to
slow the pace with which we are moving towards the post-
antibiotic era.
In chapter two a study is presented concerning the use of
antibiotics by means of analysing the total antibiotic
expenditure during the study period. Over a 10-year period
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we analysed antibiotic costs by using pharmacy surveys of
antibiotic costs and prescriptions. No increase in costs was
found but a dramatic shift in antibiotic prescription patterns
was observed, although the total antibiotic expenditure did not
increase significantly. A remarkable shift occurred from the
use of less expensive penicillins to newer, resistance-inducing
and more expensive cephalosporins and vancomycin. This
could not be explained by shifts in resistance patterns of
isolated micro-organisms. A remarkable increase in the
number of admissions or hospitalization days did not occur,
although a shift to a higher intensity of medical care could not
be ruled out. 
The total cost of antibiotics is often used by hospital boards to
monitor budgets and motivate personnel for a change in
prescribing attitudes. It is shown here that due to several
factors as marketing techniques and price cuts, this parameter
is useless for monitoring antibiotic use in the hospital. It is
necessary to study prescription patterns of antibiotics over
several years, in order to study clinically, economically and
microbiologically important shifts and relate these prescription
patterns to shifts in the patient populations. More accurate
indicators as Daily Defined Doses per 1000 hospital days
should be used, but this parameter is only practical in adult
medicine. To our knowledge until now no equivalent accurate
parameter exists for children.
In chapter three a study is presented in which we analysed the
lack of uniformity in empiric antibiotic therapy between
paediatricians end paediatric residents. Which we assessed
with the help of questionnaires with 13 clear clinical cases.
Considerable variability was found in empiric antibiotic
therapy between paediatricians and paediatric residents in the
northern part of the Netherlands. This variability was evident
for selected generic classes of antibiotics as well as for dose
and duration of therapy. Highest variability was found in
infections of the central nervous system and lowest variability
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in respiratory tract infections. In literature more agreement
could be found in the therapy of central nervous system
infections and less agreement in treatment of children with
respiratory tract infections. For the purpose of this study we
were mostly interested in the agreement between doctors
within one hospital and less in the scientifically correct choice
of antibiotics. We conclude that in order to optimise patient
care, to achieve a reduction in health care costs and to reduce
the emergence of drug resistance, antibiotics should be used
rationally. Therefore an urgent need for a more appropriate
selection and use of antibiotics exists. Clear formularies are
warranted for optimal clinical decision making resulting in the
choice of the best available product at an adequate dose for an
reasonable period of time. The formulary should be based on
the knowledge of local trends in antimicrobial resistance.
Enforcing the guidelines of the formulary should be
accompanied by a continuous commitment of all prescribers.
Finally a feedback system in which infectious disease
specialists and hospital epidemiologists should have a central
role.
In chapter four we presented a study concerning the use of
antibiotics in a paediatric university hospital. A high
percentage (35%) of all hospitalised children received
antibiotics. Over 50% of all antibiotic prescriptions were
started on an empirical basis, without confirmation of a
bacterial infection. Especially children admitted to intensive
care units and young children are at risk of receiving multiple
courses of antibiotics. In this study attention was focused on
the characteristics of the population receiving antibiotics.
Moreover the indication of antibiotic prescription was studied.
Our results are comparable with data found in studies
reported in the literature, performed more than 15 years ago.
Until now no studies have been published on the difference of
antibiotic prescriptions on different paediatric units. In our
study a significant difference could be found in percentage of
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antibiotic prescriptions and the route of administration (more
intravenous antibiotics in the Intensive Care unit) for children
admitted to the intensive care unit compared with patients
admitted on the medium care. Likewise a significant difference
in number of antibiotic courses could be found between the
former and latter group. The highest number of antibiotic
prescriptions was made for children in the youngest age group
(between 0 and 2 years). No uniformity in dose and duration
of antibiotic therapy was found. Overall we may conclude that
over the study period a shift to the use of more expensive and
broader spectrum antibiotics was seen for all groups. In order
to improve antibiotic prescribing in a hospital a more strict
and more uniform policy is warranted. This policy should be
based on local sensitivity patterns and should be revised
yearly. 
In chapter five we presented the results of a study concerning
the prescribing pattern and the acquaintance of doctors of
antibiotics. It was important to know if the daily use of
antibiotics agreed with the prescription patterns of doctors and
their knowledge of antibiotics. These items were studied by
using a semi-structured interview for thirty paediatricians.
Next to this we analysed the consequences of the introduction
of an antibiotic formulary on the uniformity in antibiotic
prescribing. Two months after the introduction of an
authorised antibiotic formulary analyses were performed to
get informed about the presence of uniformity in prescribing
behaviour of paediatricians and the use of antibiotics in daily
clinical practice in a paediatric university hospital. These data
were compared with data found in earlier studies (as
described in chapter 3 and 4). A remarkable shift towards
more uniformity in theoretical prescribing behaviour could be
found. On the other hand this could not be confirmed with the
results found for antibiotic use in daily clinical practice.
Almost the same data were found as presented in earlier
studies. Another remarkable finding was the level of
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acquaintance with 11 most commonly prescribed or used
antibiotics. This analysis showed that a very high percentage
of prescribing paediatricians was not familiar with most
important items of most commonly prescribed antibiotics in
current practice. The conclusion of this chapter was the
introduction of an authorised antibiotic formulary solely is not
enough to achieve a significant change in antibiotic prescribing
behaviour in a hospital although it can induce a learning effect.
It should always be accompanied with continuous feedback
and ongoing education programs about antibiotics and its
possible consequences.
After we studied the antibiotic costs, uniformity in antibiotic
prescribing pattern and the use of antibiotics in daily practice,
before and after the introduction of an antibiotic formulary, we
wanted to get informed about the emergence of resistance. The
duration of the research project made an extensive analysis of
data concerning resistance impossible. It is commonly known
that there is an important relationship between the use of
antibiotics and the development of resistance. Therefore we
presented in chapter six a study on clinical risk indicators for
the development of Gram-negative bacteraemia. Gram-
negative bacteraemia is a severe symptom presenting in
children and always leading to the use of antibiotics. Positive
associations between on the one hand use of antibiotics, other
drugs and indicators of intensity of care and on the other hand
the risk for Gram-negative bacteraemia could be found. This
study shows an unexpectedly strong positive and independent
association between the empirical use of vancomycin and the
existence of Gram-negative bacteraemia.
The original intent of this study was to obtain risk indicators
for Gram-negative bacteraemia from which an easily usable
clinical risk score can be constructed. Assessment of risk
indicators was performed in retrospect. In our analyses, we
have attempted to assess, within the limits of our data,
whether the association between vancomycin use and Gram-
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negative bacteraemia was genuine or biased. Use of
vancomycin showed the highest positive association with
Gram-negative bacteraemia and it was the only antibiotic that
remained positively associated with Gram-negative
bacteraemia in a multivariate analysis. Although based on
small numbers of patients, this may indicate that the positive
associations found with antibiotic combinations including
vancomycin are largely due to the exclusive effect of
vancomycin.
Ideally, in order to find a causal relation between use of
vancomycin and Gram-negative bacteraemia, one would use a
design in which empirical use of vancomycin would be
randomly allocated to children suspected of bacteraemia.
Although our results should ideally be confirmed in larger
randomised studies, it is felt that they justify particular caution
in case of empirical use of vancomycin. 
In conclusion, we find that among children suspected of
bacteraemia there are several drugs and clinical procedures
that indicate increased risk of Gram-negative bacteraemia.
Empirical use of vancomycin is strongly and independently
associated with Gram-negative bacteraemia, while its use is
not indicated for Gram-negative micro-organisms. Our study
indicates that the safety of using vancomycin solely on the
basis of suspicion of bacteraemia in children may not be
warranted.
This thesis has tried to give an overview of important aspects
in the use of antibiotics in paediatrics and its possible
consequences for now and the future. 
For the future, further research could be performed for the in
our study analysed data (antibiotic expenditure, presence of
uniformity, use of antibiotics in daily practice and
development of resistance). Not only in the department of
paediatrics, but for each specialism, in which antibiotics were
used and prescribed. It should be performed 
during a long period because a continuing registration and
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analysis is necessary as illustrated in this thesis. 
The use of vancomycin and the entity as risk factor for the
development of a Gram-negative bacteraemia gave rise to the
performance of a lot of new research. At first the
reproducibility in the current clinic and other clinics. Another
possibility is to try to rebuild the situation in an animal, as a
method for testing our hypothesis. 
These and other research possibilities could learn us more
about the use of antibiotics, the possible consequences and
how to deal with these consequences in the future.
Summary of the studies
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Nederlandstalige samenvatting
voor de niet-geneeskundige lezer
Sinds de introductie van antibiotica in het begin van de jaren
dertig wordt er op grote schaal gebruik van gemaakt. Al sinds
jaar en dag hebben antibiotica een geweldige reputatie; in de
afgelopen halve eeuw hebben deze middelen veel levens
gespaard en aan veel mensen de gezondheid teruggegeven.
Binnen de kindergeneeskunde is het een van de meest
voorgeschreven medicijnen. Diverse in het verleden
uitgevoerde studies lieten zien dat ongeveer 35% van de in het
ziekenhuis opgenomen kinderen antibiotica kregen
voorgeschreven. 
Echter door het enorme en veelal onjuiste gebruik is het nu
helaas steeds meer de beurt aan de bacterie. Vandaag de dag
zijn infecties steeds moeilijker te behandelen, wat eens een
droom was, is nu tot een nachtmerrie geworden, steeds meer
bacterin worden ongevoelig voor bepaalde antibiotica en dat
terwijl er geen nieuwe antibiotica ontwikkeld worden en we
dit de komende 10 jaar ook niet hoeven te verwachten. Naast
beschreven wereldwijde problematiek maakt ook de
kostenstijging en gebrek aan uniformiteit in voorschrijfgedrag
het van essentieel belang om rationeler en zorgvuldiger
gebruik te maken van antibiotica. Vanuit diverse professionele
organisaties wordt dit al reeds enige jaren gestimuleerd. Ook
binnen onze kliniek werd het belang hiervan en de noodzaak
hiertoe duidelijk. 
Dit was een reden om in 1995 van start te gaan met een
onderzoeksproject naar het antibioticabeleid in de Beatrix
Kinderkliniek te Groningen. 
De gedachte bestaat, dat een verbetering van het
antibioticumbeleid zich zou moeten richten op een uniformer
voorschrijfgedrag, waardoor de kosten voor antibioticagebruik
beperkt kunnen worden en de resistentieontwikkeling in de
hand te houden. Deze gedachten en bijbehorende
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uitwerkingen worden beschreven in dit proefschrift en zullen
hieronder per hoofdstuk uitgelegd worden.
Hoofdstuk n bevat een volledig overzicht van de literatuur
inclusief definities van de belangrijkste problemen van het
gebruik van antibiotica en de mogelijke oplossingen.
Na een gedetailleerde beschrijving van het gebruik,
overgebruik en misbruik van antibiotica wordt meer aandacht
besteed aan de relatie tussen voorschrijfgedrag en
ontwikkeling van resistentie. Tenslotte worden enkele
mogelijke strategien, als een verlaging van de
antibioticakosten, verhoging van de uniformiteit in
voorschrijfgedrag en een beperking van de resistentie
ontwikkeling uit de doeken gedaan. De noodzaak wordt
uitgesproken om deze mogelijke strategien spoedig te
implementeren om op deze manier een redelijke kans te
maken om het tempo te vertragen waarmee we richting het
postantibiotische tijdperk gaan, waarin we uiteindelijk de
infectieziekten niet meer kunnen behandelen met de voorheen
beschikbare en gebruikelijke antibiotica.
In hoofdstuk twee wordt de eerste studie gepresenteerd. Om
inzicht te krijgen in het antibioticagebruik en de daarmee
gepaard gaande kosten zal een analyse hiervan moeten
plaatsvinden. Om kostenverlaging te bereiken is allereerst
inzicht nodig in de huidige antibioticakosten. Het gebruik van
antibiotica over de periode 1984-1994 in de Kinderkliniek
wordt weergegeven door het analyseren van de totale
antibioticakosten middels gegevens van de apotheek over deze
periode. 
Een opvallende verschuiving vond plaats van het gebruik van
minder dure penicillines naar de nieuwere, meer resistentie
inducerende en duurdere cefalosporines en vancomycine.
Deze verschuiving kon niet verklaard worden door een
verschuiving in resistentiepatronen van de gesoleerde micro-
organismen. Ook was er niet een enorme stijging in het aantal
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opnames of opname dagen opgetreden, alhoewel een
verschuiving naar een intensievere zorg niet uitgesloten kon
worden. Ondanks deze verschuiving in het voorschrijfpatroon
van antibiotica waren de totale kosten niet gestegen. De totale
kosten van het antibioticagebruik worden vaak door het
ziekenhuisbestuur gebruikt om budgetten te beoordelen en
personeel te motiveren voor een verandering in
voorschrijfgedrag. Er kon aangetoond worden, dat door
verschillende factoren als marketing technieken en
prijsverlagingen, deze parameter niet te gebruiken is voor het
beoordelen van antibioticagebruik in het ziekenhuis. Het is
nodig om gedetailleerde voorschrijfpatronen van antibiotica
over verloop van enkele jaren te bestuderen, om klinisch,
economisch en microbiologisch belangrijke verschuivingen te
bestuderen en deze voorschrijfpatronen te relateren aan
verschuivingen in patinten populaties. Nauwkeuriger
indicatoren als Daily Defined Doses (DDD, een internationaal
gestandaardiseerde dagelijks dosis voor ieder antibiotica ) per
1000 opnamedagen zouden gebruikt moeten worden maar
deze parameter is alleen praktisch in de geneeskunde voor
volwassenen omdat in de kindergeneeskunde op
lichaamsgewicht wordt gedoseerd. Voor zover we hebben
kunnen nagaan bestaat tot op heden nog geen gelijkwaardig
nauwkeurige parameter voor kinderen.
In hoofdstuk drie wordt een studie gepresenteerd, waarin de
aan- of afwezigheid in uniformiteit in empirische antibiotica
therapie tussen kinderartsen en assistenten in de
kindergeneeskunde wordt bestudeerd. (Onder empirische
antibiotica keuze wordt verstaan, er bestaat een verdenking op
een bepaalde ziekte maar dit kan niet bevestigd worden
middels aanvullende diagnostiek of microbiologische kweken) 
De uniformiteit in antibioticakeuze wordt bestudeerd middels
een enqute met dertien duidelijke en meest voorkomende
ziektebeelden in de kindergeneeskunde. Na analyse van de
resultaten valt een grote variabiliteit op in empirische
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antibiotica therapie tussen kinderartsen en assistenten in het
noordelijk deel van Nederland. Deze variabiliteit was duidelijk
voor de geselecteerde generische klassen van antibiotica,
evenals voor de dosis en duur van de therapie. De grootste
variabiliteit werd gevonden voor centraal zenuw stelsel
infecties en de minste variabiliteit voor luchtweginfecties,
alhoewel in de literatuur juist meer overeenstemming
gevonden werd in therapie van centraal zenuw stelsel infecties
en minder overeenstemming in de behandeling van kinderen
met luchtweginfecties. Voor het doel van deze studie waren
we het meest genteresseerd in de overeenstemming tussen
dokters binnen een ziekenhuis en minder in de
wetenschappelijk juiste keuze van antibiotica. We kunnen
concluderen dat om patintenzorg te optimaliseren, tot een
reductie in de kosten voor de gezondheidszorg te komen en
om de verdere ontwikkeling van resistentie te beperken,
antibiotica rationeel gebruikt moeten worden. Daarom bestaat
er een dringende behoefte aan een uniformere selectie en
gebruik van antibiotica. Duidelijke formularia zijn
noodzakelijk voor een optimale klinische beleidsbepaling, die
resulteert in de keuze van het best beschikbare product in een
adequate dosis voor een redelijke duur van therapie. Het
formularium zou gebaseerd moeten zijn op de kennis van
lokale trends in antimicrobile resistentie. Om de richtlijnen
van het formularium kracht bij te zetten moet de introductie
van een formularium samen gaan met een continue educatie
van alle voorschrijvers. Ten slotte zal een feedback systeem
nodig zijn tijdens het voorschrijven van antibiotica, waarin
artsen gespecialiseerd in infectieziekten en
ziekenhuisepidemiologen een centrale rol innemen.
In hoofdstuk vier presenteren we een studie, die over het
gebruik van antibiotica in de dagelijkse praktijk gaat. Een hoog
percentage (35%) van alle opgenomen kinderen ontvangt
antibiotica. Meer dan 50% van alle antibiotica voorschriften
wordt gestart op een empirische basis. Er bestaat een klinische
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verdenking op een infectie maar dit wordt niet bevestigd
middels aanvullende diagnostiek of kweken. In het bijzonder
kinderen die opgenomen worden op Intensive Care
afdelingen, en jonge kinderen hebben een grote kans om
meerdere antibiotica kuren te krijgen gedurende de opname.
In deze studie was de aandacht gericht op de karakteristieken
van de kinderen, die antibiotica ontvingen. Daarnaast hebben
we de indicatie van antibiotica prescriptie bestudeerd. Onze
resultaten zijn vergelijkbaar met data gevonden in studies, die
meer dan 15 jaar geleden gerapporteerd zijn. Tot op heden zijn
geen studies gepubliceerd over het verschil in antibiotica
voorschriften en de wijzen van toediening tussen verschillende
kindergeneeskundige afdelingen. In onze studie hebben wij
een significant verschil gevonden in het percentage antibiotica
voorschriften en de wijze van toediening (meer intraveneuze
antibiotica op the Intensive Care afdeling) voor kinderen
opgenomen op de Intensive Care afdeling vergeleken met
patinten opgenomen op de Medium Care afdeling. Een
vergelijkbaar significant verschil in aantal antibiotica kuren
kon gevonden worden tussen de eerste en de laatste groep.
Het grootst aantal antibiotica voorschriften werd gemaakt voor
kinderen in de jongste leeftijdgroep (tussen 0 en 2 jaren). Er
bleek geen uniformiteit in dosis en duur van antibiotische
therapie te zijn. In het algemeen kunnen we concluderen, dat
over de studieperiode een verschuiving naar het gebruik van
duurdere en breedspectrum antibiotica werd gevonden voor
alle groepen. Om het voorschrijven van antibiotica te
verbeteren in een ziekenhuis is een strikter en uniformer beleid
van het grootste belang. Dit beleid zal gebaseerd moeten zijn
op lokale gevoeligheidspatronen en zal jaarlijks gereviseerd
moeten worden. 
In hoofdstuk vijf presenteren we de resultaten van een studie
betreffende het voorschrijfpatroon en het kennisniveau met
betrekking tot antibiotica. Dit is van belang om te evalueren of
het gebruik van antibiotica in de dagelijkse praktijk
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overeenkomt met hetgeen dokters op papier voorschrijven en
wat hun kennis van antibiotica is. Daarom hebben we gebruik
gemaakt van een semi-gestructureerd interview gehouden bij
dertig kinderartsen. Tevens hebben wij geanalyseerd of invoer
van een formularium gevolgen had voor eerder beschreven
uniformiteit in antibioticagebruik. Twee maanden na de
introductie van het formularium werd een analyse verricht
naar de aan- of afwezigheid van uniformiteit in
voorschrijfgedrag van kinderartsen en het gebruik van
antibiotica in de dagelijkse klinische praktijk in een
academische kinderafdeling. Deze data werden vergeleken
met data gevonden in eerder uitgevoerde studies (als
beschreven in hoofdstuk 3 en 4). Een belangrijke verschuiving
naar meer uniformiteit in voorschrijfgedrag werd gevonden.
De resultaten voor het antibioticagebruik in de dagelijkse
klinische praktijk zijn nauwelijks veranderd. Bijna dezelfde
resultaten werden gevonden als in eerdere uitgevoerde studie.
Een andere opmerkelijke bevinding was het kennisniveau van
kinderartsen van 11 veel voorgeschreven of gebruikte
antibiotica. Deze analyse toonde, dat een erg hoog percentage
van de voorschrijvende kinderartsen niet vertrouwd was met
de belangrijkste karakteristieken van de meest voorgeschreven
antibiotica in de dagelijkse praktijk. De conclusie van dit
hoofdstuk is dan ook, dat de introductie van een antibiotica
formularium alleen niet voldoende is om een significante
verandering te bereiken in voorschrijfgedrag in een ziekenhuis,
alhoewel het een leereffect kan induceren. De introductie of
implementatie hiervan zal altijd gepaard moeten gaan met
continue feedback bij het voorschrijven van antibiotica en
voortdurende bij- en nascholing over antibiotica en de vele
mogelijke gevolgen.
Nadat we de kosten, de uniformiteit in voorschrijfgedrag en
het gebruik van antibiotica in de dagelijkse klinische praktijk
bestudeerd hebben, zowel voor als na de introductie van het
formularium, wilden we onze aandacht richten op de
Nederlandstalige samenvatting
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resistentieontwikkeling . De duur van het onderzoek maakte
een uitvoerige analyse van resistentie gegevens echter
onmogelijk. Bekend is, dat er een belangrijke relatie bestaat
tussen antibioticagebruik en resistentieontwikkeling. Dit is er
een reden van, dat we in de volgende studie, gepresenteerd in
hoofdstuk zes, naar klinische risico indicatoren voor het
ontwikkelen van een Gram-negatieve bacteriemie ( een
voorkomen van een bacterie in de bloedbaan gepaard gaande
met ernstige ziekteverschijnselen) hebben gekeken. Gram-
negatieve bacteriemie is een ernstig symptoom voorkomend bij
kinderen en leidt altijd tot het gebruik van antibiotica. Er
werden positieve associaties tussen aan de ene kant gebruik
van antibiotica, andere medicijnen en indicatoren van
intensiteit van zorg en aan de andere kant het voorkomen van
Gram-negatieve bacteriemie gevonden. Deze studie laat een
onverwachte sterk positieve en onafhankelijke associatie zien
tussen het empirisch gebruik van vancomycine en het bestaan
van Gram-negatieve bacteriemie.
Hiervoor kunnen we mogelijke verklaringen bedenken, echter
deze zijn alle hypothetisch en zullen middels verder
onderzoek verder uitgewerkt moeten worden.
De oorspronkelijke opzet van de studie was om risico
indicatoren te herkennen voor Gram-negatieve bacteriemie,
waarvan een gemakkelijke en bruikbare klinische risico score
kan worden geconstrueerd. Het bepalen van risicofactoren
werd retrospectief uitgevoerd. In onze analyses hebben we
getracht te bepalen - binnen de grenzen van onze data - of de
associatie tussen vancomycine gebruik en Gram-negatieve
bacteriemie echt was of gebiased. Het gebruik van
vancomycine liet een significant positieve associatie met 
Gram-negatieve bacteriemie zien en het was het enige
antibioticum dat positief geassocieerd bleef met Gram-
negatieve bacteriemie in een multivariaat analyse. Alhoewel
het gebaseerd is op kleine aantallen patinten, mag dit een
aanwijzing zijn, dat de positieve associaties gevonden met
antibiotica combinaties inclusief vancomycine grotendeels het
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gevolg zijn van het exclusieve effect van vancomycine.
Alhoewel onze resultaten idealiter bevestigd zouden moeten
worden in grotere, gerandomiseerde studies, is het
gerechtvaardigd om te menen dat bijzondere voorzichtigheid
in acht genomen moet worden in het geval van empirisch
gebruik van vancomycine. 
Concluderend, hebben we gevonden dat onder kinderen
verdacht van bacteriemie verschillende medicijnen en klinische
procedures belangrijk zijn omdat ze een verhoogd risico
betekenen voor het ontwikkelen van een Gram-negatieve
bacteriemie. Empirisch gebruik van vancomycine is sterk en
onafhankelijk geassocieerd met Gram-negatieve bacteriemie,
terwijl het gebruik niet gendiceerd is voor Gram-negatieve
micro-organismen. Onze studie toont aan, dat de veiligheid
van het gebruik van vancomycine alleen op basis van de
verdenking van een bacteriemie bij kinderen niet geoorloofd is.
Dit proefschrift heeft getracht een overzicht te geven van de
belangrijkste aspecten van antibioticagebruik in de
kindergeneeskunde en de mogelijke gevolgen hiervan voor nu
en de toekomst. 
In de toekomst zal verder onderzoek gedaan moeten worden
naar de in ons onderzoek benoemde parameters (kosten,
uniformiteit, dagelijks gebruik en resistentieontwikkeling).
Niet alleen binnen de kindergeneeskunde, maar binnen ieder
specialisme waar antibiotica wordt gebruikt en
voorgeschreven. Dit zal niet voor een korte periode moeten
gelden maar er zal sprake moeten zijn van een continue
registratie en analyse van deze data. Pas dan zullen we binnen
de gezondheidszorg een zo optimaal mogelijk gebruik kunnen
maken van de huidige aanwezige antibiotica. Nieuw
ontwikkelde antibiotica zullen een duidelijker plaats krijgen,
als een ieder ervan overtuigd is zorgvuldig ermee om te gaan. 
Het gebruik van vancomycine en de entiteit als risicofactor
voor het ontwikkelen van een Gram-negatieve bacteriemie
geeft aanleiding tot het verrichten van tal van onderzoeken.
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Allereerst of we deze data kunnen reproduceren binnen een
andere kliniek. Daarnaast of we in diermodel een zelfde
situatie kunnen nabootsen. Mogelijk dat we hierdoor een van
de mogelijke hypothesen kunnen bevestigen. Waarin gesteld
wordt dat er een vermindering van de kolonisatie met Gram-
positieven door vancomycine optreedt waardoor Gram-
negatieven zich op darm niveau versterken en vervolgens in
de bloedbaan voorkomen en zich vermeerderen. 
Deze en andere onderzoeksmogelijkheden zullen ons meer
leren over het gebruik van antibiotica en de mogelijke
gevolgen voor de toekomst en hoe met deze gevolgen om te
gaan. 
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Dankwoord
Met heel veel plezier, opluchting en trots schrijf ik dit laatste
deel van mijn proefschrift. Plezier omdat het voorlopig het
einde betekent van het schrijven. Opluchting omdat het na
lang zwoegen toch nog een mooi resultaat is geworden. En
trots omdat ondanks de drukke assistententijd en de niet
geringe tegenslagen het nu toch eindelijk klaar is. 
Meerdere malen heb ik aan den lijve ondervonden, dat het
doen van onderzoek niet altijd over rozen gaat. Samen met
mijn eerste promotor Prof. dr J.L.L. Kimpen heb ik een
geweldige tijd gehad met de bij onderzoek horende ups en
downs. Met zijn tweetjes hebben we bijvoorbeeld de
posteraward binnengesleept in Kopenhagen. Samen is het toch
gelukt om het eerste artikel kwijt te raken. Steeds stak je me
een hart onder de riem door te zeggen dat het wel goed zal
komen en dat het ook jou veel tijd kostte om jouw eerste
artikel te slijten. Ik had deze periode voor geen goud willen
missen en het is nu denk ik tijd voor de fles wijn die ik je bij
jouw afscheid in Groningen gegeven heb.
Mijn tweede promotor, Prof. dr P.J.J. Sauer bedankt dat u bij
het vertrek van Jan uit Groningen mij verder heeft willen
begeleiden. En dat u samen met mij de introductie van het
antibiotica formularium uiteindelijk tot een succes gemaakt
heeft. 
Cuno Uiterwaal, mijn co-promotor, pas op het laatst raakte je
betrokken bij mijn onderzoek. Helaas kon je geen
veranderingen meer aanbrengen aan de opzet van sommige
delen van het onderzoek. Bedankt voor je grenzeloze geduld,
voorzichtigheid en inventiviteit met betrekking tot de
statistische analyses. Het communiceren per e-mail met jou is
een waar genot.
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De leden van de promotiecommissie; Prof. dr I.M. Hoepelman,
Prof. dr H.S.A. Heymans, Prof. dr J.E. Degener, 
Prof. dr A.J. van Vught en Prof. dr Th.J.M. Verhey bedankt
voor het beoordelen van het proefschrift. Ik vind het een eer
dat u zitting wilde nemen in de promotiecommissie.
Ik dank alle Groningse dokters voor hun geweldige inzet en
enthousiasme, waarmee iedereen elke keer weer meegedaan
heeft met de door mij opgezette interviews, enqutes en
andere activiteiten. De drie jaar die mijn onderzoek geduurd
heeft zouden heel anders verlopen zijn zonder jullie
enthousiaste medewerking. 
Ook de arts-assistenten droegen mijn onderzoek een warm
hart toe. Nooit was iemand te beroerd om een antwoord te
geven op de vraag ÒWaarom heb je dat middel voorge-
schrevenÓ. Daarnaast heb ik het altijd bijzonder gewaardeerd,
dat wij als onderzoekers werden opgenomen in de assistenten-
groep en mee mochten doen aan al jullie activiteiten.  
Mijn collega-onderzoekers te weten Marion Grol, Femke van
Overbeek, Jan-Peter Rake, Aline Sprikkelman, Peter Dijk en
Martin Visser dank ik voor de geweldige tijd, die we samen
hebben meegemaakt. Pas achteraf realiseer ik mij hoe luxe en
gezellig het leven van een onderzoeker is. Die momenten van
gezelligheid mis ik soms nog als ik hardwerkend in de kliniek
loop of step. 
Bedankt Han Marra, Jannie Tjassing, Henritte Oldhoff en later
Neelie Schouten voor jullie altijd vriendelijke medewerking, de
gezellige praatjes en wat niet meer.
Bedankt Max Brons voor het altijd maar weer verstrekken van
de gegevens. De computer werkte niet altijd zoals jij wilde,
maar uiteindelijk lukte het je altijd om mij de gegevens aan te
leveren binnen zeer korte tijd.
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Bedankt mensen van de apotheek, in het bijzonder Marian
Laseur en Klarieke Luinge voor hun bijdrage aan mijn
onderzoek. Jullie enthousiasme over de resultaten van het
onderzoek gaven mij altijd weer het enthousiasme om met
volle kracht verder te gaan.
Ook de gegevens die ik via jullie boven water heb gekregen,
zijn onmisbaar geweest voor het uiteindelijke resultaat van
mijn onderzoek. Het werken met informatie via ÔfichesÕ gaf een
extra dimensie aan het verzamelen van de gegevens voor mijn
onderzoek.
Bedankt iedereen van de afdeling Medische Microbiologie en
Ziekenhuisepidemiologie, vooral Prof. dr J.E. Degener, 
Jan Arends en Rene Benne. Nooit was een vraag jullie te veel
en werden de door mij gevraagde gegevens op flop gegeven.
Bedankt, dat ik mee heb mogen lopen om meer inzicht te
krijgen in het wel en wee van de afdeling Medische
Microbiologie. 
Carien Miedema, we zijn vrijwel gelijktijdig begonnen in
Groningen en vormden met Jan samen een klein maar hecht
groepje. Het doen van de polikliniek Infectieziekten gaf mij
extra motivatie om de kliniek in te duiken. Jij wilde me wel
overal mee heenslepen, maar je werd veelal afgeremd door
Jan. Bedankt voor jouw vriendschap en alles wat je me van de
kindergeneeskunde geleerd hebt.
De projectgroep; Jan Kimpen, Carien Miedema, Marian Laseur,
Jan Arends, Jorrit Gerritsen, Hennie Knoester, Rienk Tamminga,
Klazien Bergman, Freddy Kokke en Sjef van Gestel, jullie
inbreng heeft veel resultaat gehad. De knelpunten in het
huidige antibioticabeleid werden geformuleerd en er werd
tevens een consensus gedefinieerd, van waaruit het onderzoek
verder gestalte kon krijgen. Uiteindelijk hebben we gemerkt,
dat de grootste moeilijkheid bestaat om alle dokters een zelfde
kant op te laten kijken.
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Raad van Bestuur van het Academisch Ziekenhuis te
Groningen, bedankt voor het vertrouwen, dat jullie hadden om
dit onderzoek op te starten en te voorzien van een financile
bijdrage. Ook de continuering van het onderzoek voor het
derde jaar is door jullie mogelijk gemaakt. Uiteindelijk heeft
het onderzoek zichzelf dubbel en dwars terugbetaald en zal nu
zelfs een soortgelijk onderzoek worden opgezet binnen de
Interne Kliniek.
Studenten Geneeskunde; Sietze Munneke, Anniek Koolman,
Patricia MacLean en Ghislaine Heesen. Ook jullie dank ik voor
de geweldige hoeveelheid werk die jullie verricht hebben met
meestal veel enthousiasme en plezier. Zonder jullie hulp had
ik nachten achter elkaar mogen doorwerken. Ik hoop dat ik
jullie heb mogen bijbrengen dat het doen van onderzoek
weliswaar erg leuk en interessant is, maar dat je alleen niet ver
komt.
Mijn collegaÕs en bazen uit Utrecht en Nieuwegein bedankt
voor jullie medewerking, flexibiliteit en ook voor de
gezelligheid. Zonder jullie was het nooit geworden tot het
huidige resultaat.
Mijn paranimfen, Debby Geysen en Yolande Thomasse ben ik
erg dankbaar. Jullie vriendschap, humor en enthousiasme
betekenen erg veel voor mij.
Ook andere vrienden direct en minder nauw betrokken bij
mijn onderzoek dank ik voor hun vriendschap. En voor het feit
dat ze altijd een luisterend oor konden bieden aan het wel en
wee van mijn onderzoek. 
Papa en Mama bedankt voor jullie grenzeloze geduld, ook in
moeilijker periodes. Jullie hebben ons altijd omringd met liefde
en warmte en de mogelijkheid geschapen tot het uitvoeren van
zaken, die we echt wilden. 
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Tjibbe en Christa, het hebben van een broer en een zus is een
voorrecht en het goed met elkaar kunnen vinden is een geluk.
Bedankt voor de gezellige tijd samen, de humor en jullie
indirecte bijdrage aan mijn boekje.
Lieve Max, bedankt voor jouw bijdrage aan mijn proefschrift.
Jouw voortreffelijke kennis van de Nederlandse taal en
grammatica bleek voor mij van groot belang. Het verzorgen
van een goede infrastructuur om goed te kunnen werken is
aan jou wel toevertrouwd. 
Een gouden toekomst ligt nu hopelijk voor ons klaar.
Marlies
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